田中 榮司 (タナカ エイジ)   

医学部 医学科 地域医療推進学 

特任教授 

学位

  • 博士(医学), 信州大学

研究キーワード

    ウイルス肝炎, 自己免疫性肝疾患, 代謝性肝疾患

研究分野

  • 消化器内科学, 消化器内科学

経歴

  • 2008年
    信州大学(医学部) 教授
  • 2007年 - 2008年
    信州大学(医学部) 准教授
  • 2001年 - 2007年
    信州大学(医学部) 助教授
  • 1995年 - 2001年
    信州大学(医学部) 講師
  • 1988年 - 1995年
    信州大学(医学部) 助手

学歴

  • 1982年, 信州大学, 医学研究科
  • 1978年, 金沢大学, 医学部

委員歴

  • 評議員, 日本内科学会
  • 財団評議員, 日本消化器病学会
  • 理事, 日本肝臓学会

論文

  • Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma
    Sato K, Uehara T, Iwaya M, Nakajima T, Miyagawa Y, Ota H, Tanaka E
    Ann Diagn Pathol, 48, 151587, 2020年10月
    最終著者
  • Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B
    Matsumoto A, Nishiguchi S, Enomoto H, Tanaka Y, Shinkai N, Okuse C, Kang JH, Matsui T, Miyase S, Yatsuhashi H, Nagaoka S, Kanda T, Enomoto M, Yamada R, Hiramatsu N, Saito S, Takaguchi K, Ito K, Masaki T, Morihara D, Tsuge M, Chayama K, Ikeda F, Kagawa T, Kondo Y, Murata K, Tanaka E
    J Gastroenterol, 55(10), 977-989, 2020年10月
    最終著者
  • Clinical impact of normal alanine aminotransferase on direct-acting antiviral outcome in patients with chronic hepatitis C virus infection
    Joshita S, Sugiura A, Umemura T, Yamazaki T, Fujimori N, Matsumoto A, Usami Y, Tanaka E
    JGH Open, 4(4), 574-581, 2020年08月
    最終著者
  • Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus
    Fujimori N, Tanaka N, Kimura T, Sano K, Horiuchi A, Kato N, Takahashi Y, Kuribayashi N, Sugiura A, Yamazaki T, Joshita S, Umemura T, Matsumoto A, Tanaka E
    Clin J Gastroenterol, 13(1), 83-89, 2020年02月
    最終著者
  • Diffuse large B-cell lymphoma of the colon and rectum in a patient with colonic Crohn's disease treated with infliximab and azathioprine
    Sato K, Suga T, Hirayama A, Daikuhara S, Uehara T, Tanaka E
    Clin J Gastroenterol, 13(1), 1-5, 2020年02月
    最終著者
  • Virological Factors Associated With the Occurrence of Hepatitis B Virus (HBV) Reactivation in Patients With Resolved HBV Infection Analyzed Through Ultradeep Sequencing
    Sakamoto K, Umemura T, Ito K, Okumura A, Joshita S, Ota M, Sugiyama M, Mizokami M, Yoneda M, Tanaka E
    J Infect Dis, 221(3), 2020年01月
    最終著者
  • 【内科医が知っておくべき肝移植の実際】脳死肝移植レシピエントの適応と選択 令和になっての改訂
    田中榮司
    消化器・肝臓内科, 7(3), 231-237, 2020年
    筆頭著者
  • 既存抗ウイルス療法の限界
    田中榮司
    臨床消化器内科, 35(2), 125-126, 2020年
    筆頭著者
  • 胆嚢癌との鑑別が困難な画像所見を呈した胆嚢線維性ポリープの1例
    芦原典宏, 渡邉貴之, 倉石康弘, 小澤真希子, 中村晃, 金井圭太, 大月聡明, 浜野英明, 田中榮司
    胆道, 33(5), 854-861, 2019年12月
  • Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis
    Joshita S, Yamashita Y, Sugiura A, Uehara T, Usami Y, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E, Umemura T
    J Gastroenterol Hepatol, 2019年11月
  • KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis
    Umemura T, Joshita S, Saito H, Yoshizawa K, Norman GL, Tanaka E, Ota M
    JHEP Rep, 1(5), 353-360, 2019年11月
  • Correlation of clinicopathological features and leucine-rich repeat-containing G-protein-coupled receptor 5 expression in pancreatic ductal adenocarcinoma
    Kuraishi Y, Uehara T, Kobayashi Y, Nakajima T, Watanabe T, Shimizu A, Ota H, Tanaka E:
    Pathol Res Pract, 215(11), 152623, 2019年11月
  • Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis
    Joshita S, Umemura T, Yamashita Y, Sugiura A, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E
    Hepatol Res, 49(10), 1236-1243, 2019年10月
  • 嚢胞周囲に限局した自己免疫性膵炎の1例
    小澤真希子, 渡邉貴之, 芦原典宏, 倉石康弘, 中村晃, 金井圭太, 松本有機, 小林実喜子, 田中榮司
    膵臓, 34(5), 239-246, 2019年10月
  • Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society
    Umeshita K, Eguchi S, Egawa H, Haga H, Kasahara M, Kokudo N, Sakisaka S, Takada Y, Tanaka E, Eguchi H, Uemoto S, Ohdan H
    Hepatol Res, 49(9), 964-980, 2019年09月
  • Efficacy and safety of eradication therapy for elderly patients with helicobacter pylori infection
    Kobayashi S, Joshita S, Yamamoto C, Yanagisawa T, Miyazawa T, Miyazawa M, Kubota D, Sato J, Umemura T, Tanaka E
    Medicine (Baltimore), 98(30), e16619, 2019年07月
  • What will happen in patients with advanced nonalcoholic fatty liver
    Kimura T, Tanaka N, Tanaka E
    Hepatobiliary Surg Nutr, 8(3), 283-285, 2019年06月
  • Response to the letter by Matsushita et al. regarding our manuscript "Resection Depth and Layer of Cold Snare Polypectomy versus Endoscopic Mucosal Resection"
    Suga T, Ito A, Ota H, Tateiwa N, Matsumoto A, Tanaka E
    J Gastroenterol, 54(5), 473, 2019年05月
  • 【肝臓病学の未来-ウイルス性肝炎から脂肪肝と肝がんの時代へ】NAFLD/NASH 期待される新薬
    田中直樹, 木村岳史, 藤森尚之, 田中榮司
    内科, 123(5), 1155-1158, 2019年05月
  • Red plasma and ascites under ultraviolet A
    Wakabayashi SI, Kimura T, Tanaka N, Komatsu M, Tanaka E
    Lancet Gastroenterol Hepatol, 4(4), 324, 2019年04月
  • A Case of Adult T-Cell Leukemia/Lymphoma Complicated with Bilateral Chylothorax
    Kako S, Joshita S, Matsuo A, Kawaguchi K, Umemura T, Tanaka E
    Case Rep Oncol Med, 8357893, 2019年03月
  • Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study
    Umemura T, Joshita S, Shibata S, Sugiura A, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E
    Medicine (Baltimore), 98(6), e14475, 2019年02月
  • 【消化器癌の危険因子・予防対策】 肝臓癌のリスクファクターと予防対策 肝炎ウイルス以外
    田中直樹, 木村岳史, 藤森尚之, 田中榮司
    消化器・肝臓内科, 5(2), 215-221, 2019年02月
  • ウイルス肝炎と歩んだ40年
    田中榮司
    信州医学雑誌, 67(1), 27-30, 2019年02月
  • Current status, problems, and perspectives of non-alcoholic fatty liver disease research
    Tanaka N, Kimura T, Fujimori N, Nagaya T, Komatsu M, Tanaka E
    World J Gastroenterol, 25(2), 163-177, 2019年01月
  • Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients
    Komatsu M, Tanaka N, Kimura T, Fujimori N, Sano K, Horiuchi A, Sugiura A, Yamazaki T, Shibata S, Joshita S, Umemura T, Matsumoto A, Tanaka E
    Hepatol Res, 48(13), 1092-1098, 2018年12月
  • Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals
    Sugiura A, Joshita S, Umemura T, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Usami Y, Wada S, Mori H, Shibata S, Yoshizawa K, Morita S, Furuta K, Kamijo A, Iijima A, Kako S, Maruyama A, Kobayashi M, Komatsu M, Matsumura M, Miyabayashi C, Ichijo T, Takeuchi A, Koike Y, Gibo Y, Tsukadaira T, Inada H, Kiyosawa K, Tanaka E
    J Viral Hepat, 25(12), 1462-1471, 2018年12月
  • Resection depth and layer of cold snare polypectomy versus endoscopic mucosal resection
    Ito A, Suga T, Ota H, Tateiwa N, Matsumoto A, Tanaka E
    J Gastroenterol, 53(11), 1171-1178, 2018年11月
  • Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C
    Umemura T, Yamazaki T, Joshita S, Sugiura A, Fujimori N, Matsumoto A, Ota M, Tanaka E
    CYTOKINE, 111, 357-363, 2018年10月
  • Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma
    Wakabayashi SI, Kimura T, Tanaka N, Joshita S, Kawata K, Umemura T, Hiroshima Y, Mori H, Kobayashi H, Wada S, Tanaka E
    Clin J Gastroenterol, 11(4), 302-308, 2018年08月
  • A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis
    Yamazaki T, Umemura T, Joshita S, Yoshizawa K, Tanaka E, Ota M
    Sci Rep, 8(1), 11924, 2018年08月
  • Hepatic Angiosarcoma with Kasabach-Merritt Phenomenon: A Case Report and Review of the Literature
    Fujii F, Kimura T, Tanaka N, Kubota D, Sugiura A, Umemura T, Wada S, Tanaka E
    Ann Hepatol, 17(4), 655-660, 2018年07月
  • Accuracy of Endoscopic Diagnosis for Mild Atrophic Gastritis Infected with Helicobacter pylori
    Okamura T, Iwaya Y, Kitahara K, Suga T, Tanaka E
    Clin Endosc, 51(4), 362-367, 2018年07月
  • Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis
    Joshita S, Umemura T, Usami Y, Yamashita Y, Norman GL, Sugiura A, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Yoshizawa K, Ota M, Tanaka E
    Sci Rep, 8(1), 8159, 2018年05月
  • Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma
    Sawai H, Nishida N, Khor SS, Honda M, Sugiyama M, Baba N, Yamada K, Sawada N, Tsugane S, Koike K, Kondo Y, Yatsuhashi H, Nagaoka S, Taketomi A, Fukai M, Kurosaki M, Izumi N, Kang JH, Murata K, Hino K, Nishina S, Matsumoto A, Tanaka E, Sakamoto N, Ogawa K, Yamamoto K, Tamori A, Yokosuka O, Kanda T, Sakaida I, Itoh Y, Eguchi Y, Oeda S, Mochida S, Yuen MF, Seto WK, Poovorawan Y, Posuwan N, Mizokami M, Tokunaga K
    Sci Rep, 8(1), 7958, 2018年05月
  • A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature
    Yamazaki T, Joshita S, Kasuga E, Horiuchi K, Sugiura A, Fujimori N, Komatsu M, Umemura T, Matsumoto A, Tanaka E
    J Infect Chemother, 24(5), 393-397, 2018年05月
  • Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
    Kimura T, Tanaka N, Fujimori N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Umemura T, Matsumoto A, Tanaka E
    World J Gastroenterol, 24(13), 1440-1450, 2018年04月
  • KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients
    Saito H, Umemura T, Joshita S, Yamazaki T, Fujimori N, Kimura T, Komatsu M, Matsumoto A, Tanaka E, Ota M
    Oncotarget, 9(28), 19650-19661, 2018年04月
  • Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
    Fujimori N, Umemura T, Kimura T, Tanaka N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Usami Y, Sano K, Igarashi K, Matsumoto A, Tanaka E
    World J Gastroenterol, 24(11), 1239-1249, 2018年03月
  • Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection
    Joshita S, Ichikawa Y, Umemura T, Usami Y, Sugiura A, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Igarashi K, Ota M, Tanaka E
    Hepatol Res, 48(4), 275-285, 2018年03月
  • Living donor liver transplantation for biliary atresia: An analysis of 2085 cases in the registry of the Japanese Liver Transplantation Society
    Kasahara M, Umeshita K, Sakamoto S, Fukuda A, Furukawa H, Sakisaka S, Kobayashi E, Tanaka E, Inomata Y, Kawasaki S, Shimada M, Kokudo N, Egawa H, Ohdan H, Uemoto S
    Am J Transplant, 18(3), 659-668, 2018年03月
  • 長期経過加療中の非肝硬変期に肝細胞癌を合併した原発性胆汁性胆管炎の2例
    杉浦亜弓, 城下智, 山下裕騎, 木村岳史, 山崎智生, 藤森尚之, 小松通治, 松本晶博, 小林翔太, 梅村武司, 田中榮司
    信州医学雑誌, 66(1), 39-49, 2018年02月10日リポジトリ
  • Genetics and epigenetics in the pathogenesis of primary biliary cholangitis
    Joshita S, Umemura T, Tanaka E, Ota M
    Clin J Gastroenterol, 11(1), 11-18, 2018年02月
  • Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy
    Matsumoto A, Nishiguchi S, Enomoto H, Kang JH, Tanaka Y, Shinkai N, Kurosaki M, Enomoto M, Kanda T, Yokosuka O, Yatsuhashi H, Nagaoka S, Okuse C, Kagawa T, Mine T, Takaguchi K, Saito S, Hino K, Ikeda F, Sakisaka S, Morihara D, Miyase S, Tsuge M, Chayama K, Hiramatsu N, Suzuki Y, Murata K, Tanaka E
    J Gastroenterol, 53(2), 247-257, 2018年02月
  • Induction of IFN-lambda3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection
    Murata K, Asano M, Matsumoto A, Sugiyama M, Nishida N, Tanaka E, Inoue T, Sakamoto M, Enomoto N, Shirasaki T, Honda M, Kaneko S, Gatanaga H, Oka S, Kawamura YI, Dohi T, Shuno Y, Yano H, Mizokami M
    Gut, 67(2), 362-371, 2018年02月
  • Salmonella Enteritidis cholecystitis with chronic granulomatous disease
    Yamashita Y, Kimura T, Tanaka N, Yazaki M, Itagaki T, Joshita S, Umemura T, Matsumoto A, Mori H, Wada S, Tanaka E
    IDCases, 12, 49-52, 2018年
  • Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population
    Saito H, Hirayama A, Umemura T, Joshita S, Mukawa K, Suga T, Tanaka E, Ota M
    PLOS ONE, 13(4), e0195778, 2018年
  • Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C
    Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Ota M, Tanaka E
    PLOS ONE, 13(4), e0195632, 2018年
  • Association of autoimmune hepatitis with Src homology 2 adaptor protein 3 gene polymorphisms in Japanese patients
    Umemura T, Joshita S, Hamano H, Yoshizawa K, Kawa S, Tanaka E, Ota M
    J Hum Genet, 62(11), 963-967, 2017年11月
  • Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury
    Fujimori N, Komatsu M, Tanaka N, Iwaya M, Nakano H, Sugiura A, Yamazaki T, Shibata S, Iwaya Y, Muraki T, Ichikawa Y, Kimura T, Joshita S, Umemura T, Matsumoto A, Tanaka E
    Clin J Gastroenterol, 10(5), 452-458, 2017年10月
  • Survival in patients with Child-Pugh class C cirrhosis: Analysis of the liver transplant registry in Japan
    Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y, The Assessment Committee of Indication for Transplantation
    Hepatol Res, 47(11), 1155-1164, 2017年10月
  • Association between lower air pressure and the onset of ischemic colitis: a case-control study
    Kimura T, Shinji A, Tanaka N, Koinuma M, Yamaura M, Nagaya T, Joshita S, Komatsu M, Umemura T, Horiuchi A, Wada S, Tanaka E
    Eur J Gastroenterol Hepatol, 29(9), 1071-1078, 2017年09月
  • 【ウイルス肝炎のすべて】血液伝播するウイルス肝炎 B型肝炎 B型肝炎に対する核酸アナログ/インターフェロン併用療法
    梅村武司, 田中榮司
    医学のあゆみ, 262(14), 1336-1340, 2017年09月
  • Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis
    Umemura T, Sekiguchi T, Joshita S, Yamazaki T, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Shums Z, Norman GL, Tanaka E, Ota M
    Liver Int, 37(6), 897-905, 2017年06月
  • Successful Treatment for Chronic Hepatitis C-Autoimmune Hepatitis Overlap Syndrome due to Daclatasvir and Asunaprevir
    Sugiura A, Wada S, Mori H, Kimura T, Matsuda Y, Tanaka N, Tanaka E, Kiyosawa K
    Case Rep Gastroenterol, 11(2), 305-311, 2017年05月
  • Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody
    Matsumoto A, Imaizumi M, Tanaka Y, Nishiguchi S, Yatsuhashi H, Ishida T, Moriyama K, Aoyagi K, Tanaka E
    J Gastroenterol, 52(3), 376-384, 2017年05月
  • 【混合型肝癌をめぐる混乱の終焉を目指して】 混合型肝癌[ICD-0 code 8180/3(WHO2010)]の画像診断
    上田和彦, 平塚真生子, 松枝清, 高澤豊, 笹平直樹, 齋浦明夫, 田中榮司, 宮川眞一
    肝・胆・膵, 74(5), 761-767, 2017年05月
  • 6年間に40回以上の内視鏡的バルーン拡張術を要した食道慢性GVHDの1例
    平山敦大, 菅智明, 大野和幸, 小林惇一, 齊藤博美, 日原 優, 横田有紀子, 伊東哲宏, 中村麗那, 北畠央之, 田中景子, 岡村卓磨, 田中榮司
    ENDOSCOPIC FORUM for digestive disease, 33(1), 51, 2017年05月
  • Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C
    Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Igarashi K, Tanaka E
    Sci Rep, 7, 46705, 2017年04月
  • Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection
    Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Horiuchi A, Mori H, Wada S, Kiyosawa K, Miyagawa SI, Tanaka E
    Hepatol Res, 47(5), 405-418, 2017年04月
  • 関節リウマチ治療中に発症した悪性リンパ腫の1例
    酒井均, 川上徹, 須藤祐里子, 仁科さやか, 妹尾紀子, 中澤英之, 田中榮司
    長野県医学会雑誌, 47, 101, 2017年03月
  • IgG4関連疾患における悪性腫瘍発症
    浅野純平, 渡邉貴之, 北野真希子, 中村晃, 伊藤哲也, 田中榮司
    長野県医学会雑誌, 47, 26-27, 2017年03月
  • 【内科領域におけるウイルス感染症〜ウイルス感染症に対する最新の知識と治療〜】 日常遭遇することの多いウイルス感染症 肝炎領域 B型肝炎
    田中榮司
    日本内科学会雑誌, 106(3), 422-427, 2017年03月
  • Development of diffuse large B-cell lymphoma from follicular lymphoma of the duodenum: changes in endoscopic findings during a 6-year follow-up
    Kitabatake H, Nagaya T, Tanaka N, Ota H, Sano K, Asano N, Suga T, Nakamura Y, Akamatsu T, Tanaka E
    Clin J Gastroenterol, 10(1), 79-85, 2017年02月
  • Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection
    Ichikawa Y, Joshita S, Umemura T, Shobugawa Y, Usami Y, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Tanaka E
    Hepatol Res, 47(2), 226-233, 2017年02月
  • Massive ascites caused by intra-pancreatic arterioportal fistula: a rare complication of chronic pancreatitis
    Yamazaki T, Ochi Y, Tanaka N, Watanabe T, Iwaya Y, Seki A, Hara E, Tanaka E, Watanabe T, Imai S, Hasebe O
    Clin J Gastroenterol, 10(1), 73-78, 2017年02月
  • Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population
    Kawashima M, Hitomi Y, Aiba Y, Nishida N, Kojima K, Kawai Y, Nakamura H, Tanaka A, Zeniya M, Hashimoto E, Ohira H, Yamamoto K, Abe M, Nakao K, Yamagiwa S, Kaneko S, Honda M, Umemura T, Ichida T, Seike M, Sakisaka S, Harada M, Yokosuka O, Ueno Y, Senju M, Kanda T, Shibata H, Himoto T, Murata K, Miyake Y, Ebinuma H, Taniai M, Joshita S, Nikami T, Ota H, Kouno H, Kouno H, Nakamuta M, Fukushima N, Kohjima M, Komatsu T, Komeda T, Ohara Y, Muro T, Yamashita T, Yoshizawa K, Nakamura Y, Shimada M, Hirashima N, Sugi K, Ario K, Takesaki E, Naganuma A, Mano H, Yamashita H, Matsushita K, Yamauchi K, Makita F, Nishimura H, Furuta K, Takahashi N, Kikuchi M, Masaki N, Tanaka T, Tamura S, Mori A, Yagi S, Shirabe K, Komori A, Migita K, Ito M, Nagaoka S, Abiru S, Yatsuhashi H, Yasunami M, Shimoda S, Harada K, Egawa H, Maehara Y, Uemoto S, Kokudo N, Takikawa H, Ishibashi H, Chayama K, Mizokami M, Nagasaki M, Tokunaga K, Nakamura M
    Hum Mol Genet, 23(3), 650-659, 2017年02月
  • Association between endotoxemia and histological features of nonalcoholic fatty liver disease
    Kitabatake H, Tanaka N, Fujimori N, Komatsu M, Okubo A, Kakegawa K, Kimura T, Sugiura A, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Koinuma M, Sano K, Aoyama T, Tanaka E
    World J Gastroenterol, 23(4), 712-722, 2017年01月
  • The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study
    Taida T, Arai M, Kanda T, Hige S, Ueno Y, Imazeki F, Izumi N, Tanaka E, Shinkai N, Yoshioka K, Nakamoto Y, Nishiguchi S, Tsuge M, Abe M, Sata M, Yatsuhashi H, Ido A, Kita K, Azemoto R, Kitsukawa Y, Goto N, Yokosuka O
    J Gastroenterol, 52(1), 113-122, 2017年01月
  • 【エキスパートが教える薬の使い方×エビデンスの調べ方】 (第1章)よくある疾患に対する薬の使い分け 肝炎
    梅村武司, 田中榮司
    薬事, 59(2), 280-284, 2017年01月
  • The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study.
    Taida T, Arai M, Kanda T, Hige S, Ueno Y, Imazeki F, Izumi N, Tanaka E, Shinkai N, Yoshioka K, Nakamoto Y, Nishiguchi S, Tsuge M, Abe M, Sata M, Yatsuhashi H, Ido A, Kita K, Azemoto R, Kitsukawa Y, Goto N, Yokosuka O
    J Gastroenterol, 52(1), 113-122, 2017年01月電子ジャーナル
  • Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
    Joshita S, Umemura T, Tanaka E, Ota M
    J Immunol Res, 3073504, 2017年
  • Survival in patients with Child-Pugh class C cirrhosis: analysis of the liver transplant registry in Japan.
    Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y
    Hepatol Res, in press, 2016年12月電子ジャーナル
  • Massive ascites caused by intra-pancreatic arterioportal fistula: a rare complication of chronic pancreatitis.
    Yamazaki T, Ochi Y, Tanaka N, Watanabe T, Iwaya Y, Seki A, Hara E, Tanaka E, Watanabe T, Imai S, Hasebe O
    Clin J Gastroenterol, in press, 2016年12月電子ジャーナル
  • Development of diffuse large B-cell lymphoma from follicular lymphoma of the duodenum: changes in endoscopic findings during a 6-year follow-up.
    Kitabatake H, Nagaya T, Tanaka N, Ota H, Sano K, Asano N, Suga T, Nakamura Y, Akamatsu T, Tanaka E
    Clin J Gastroenterol, in press, 2016年11月電子ジャーナル
  • Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis.
    Umemura T, Sekiguchi T, Joshita S, Yamazaki T, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Shums Z, Norman GL, Tanaka E, Ota M
    Liver Int, in press, 2016年11月電子ジャーナル
  • Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society.
    Umeshita K, Inomata Y, Furukawa H, Kasahara M, Kawasaki S, Kobayashi E, Kokudo N, Sakisaka S, Shimada M, Tanaka E, Uemoto S; Japanese Liver Transplantation Society.
    Hepatol Res, 46(12), 1171-1186, 2016年11月電子ジャーナル
  • Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.
    Murata K, Asano M, Matsumoto A, Sugiyama M, Nishida N, Tanaka E, Inoue T, Sakamoto M, Enomoto N, Shirasaki T, Honda M, Kaneko S, Gatanaga H, Oka S, Kawamura YI, Dohi T, Shuno Y, Yano H, Mizokami M
    Gut, in press, 2016年10月電子ジャーナル
  • Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations.
    Mori KI, Matsumoto A, Maki N, Ichikawa Y, Tanaka E, Yagi S
    BMC Microbiol, 16(1), 224, 2016年09月電子ジャーナル
  • Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis.
    Fujimori N, Tanaka N, Shibata S, Sano K, Yamazaki T, Sekiguchi T, Kitabatake H, Ichikawa Y, Kimura T, Komatsu M, Umemura T, Matsumoto A, Tanaka E
    Hepatol Res, 46(10), 1019-27, 2016年09月電子ジャーナル
  • A case of simultaneous esophageal squamous cell carcinoma and Barrett's adenocarcinoma.
    Yamazaki T, Iwaya Y, Iwaya M, Watanabe T, Seki A, Ochi Y, Hara E, Sekiguchi T, Hosaka N, Arakura N, Tanaka E, Hasebe O
    Clin J Gastroenterol, 9(4), 222-7, 2016年08月電子ジャーナル
  • Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan.
    Yoshizawa K, Joshita S, Matsumoto A, Umemura T, Tanaka E, Morita S, Maejima T, Ota M
    Hepatol Res, 46(9), 878-83, 2016年08月電子ジャーナル
  • Liver stiffness-spleen size-to-platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C.
    Shibata S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E
    Hepatol Res, 46(9), 884-9, 2016年08月電子ジャーナル
  • Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody.
    Matsumoto A, Imaizumi M, Tanaka Y, Nishiguchi S, Yatsuhashi H, Ishida T, Moriyama K, Aoyagi K, Tanaka E
    J Gastroenterol, in press, 2016年07月
  • Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan.
    Umemura T, Joshita S, Yamazaki T, Komatsu M, Katsuyama Y, Yoshizawa K, Tanaka E, Ota M
    Sci Rep, 6, 29770, 2016年07月電子ジャーナル
  • Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease.
    Shibata S, Joshita S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Komatsu M, Matsumoto A, Tanaka E
    Springerplus, 5(1), 998, 2016年07月電子ジャーナル
  • Case of Barrett's adenocarcinoma with marked endoscopic morphological changes in Barrett's esophagus over a long follow-up period of 15 years.
    Iwaya Y, Yamazaki T, Watanabe T, Seki A, Ochi Y, Hara E, Arakura N, Tanaka E, Hasebe O
    Dig Endosc, 28(5), 607-10, 2016年07月電子ジャーナル
  • Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.
    Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Horiuchi A, Mori H, Wada S, Kiyosawa K, Miyagawa SI, Tanaka E
    Hepatol Res, in press, 2016年06月電子ジャーナル
  • Severe hepatotoxicity associated with asunaprevir and daclatasvir in chronic hepatitis C.
    Shibata S, Umemura T, Komatsu M, Tanaka E
    Hepatology, 63(6), 2063-4, 2016年06月電子ジャーナル
  • A Case of Esophageal Hemangioma Successfully Treated by Endoscopic Injection Sclerotherapy
    Suga Tomoaki, Okamura Takuma, Iwaya Yugo, Ito Tetsuya, Arakura Norikazu, Umemura Takeji, Tanaka Eiji
    信州医学雑誌, 64(2), 75-78, 2016年04月10日リポジトリ
  • Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis.
    Nishida N, Ohashi J, Khor SS, Sugiyama M, Tsuchiura T, Sawai H, Hino K, Honda M, Kaneko S, Yatsuhashi H, Yokosuka O, Koike K, Kurosaki M, Izumi N, Korenaga M, Kang JH, Tanaka E, Taketomi A, Eguchi Y, Sakamoto N, Yamamoto K, Tamori A, et al
    Sci Rep, 6, 24767, 2016年04月電子ジャーナル
  • Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Ichikawa Y, Joshita S, Umemura T, Shobugawa Y, Usami Y, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Tanaka E
    Hepatol Res, in press, 2016年03月電子ジャーナル
  • The loop-forming method as a useful technique to rotate the endoscopic insertion tube shaft.
    Suga T, Okamura T, Arakura N, Tanaka E
    Endosc Int Open, 4(2), E170-4, 2016年02月電子ジャーナル
  • JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2.
    Asahina Y, Izumi N, Hiromitsu K, Kurosaki M, Koike K, Suzuki F, Takikawa H, Tanaka A, Tanaka E, Tanaka Y, Tsubouchi H, Hayashi N, Hiramatsu N, Yotsuyanagi H
    Hepatol Res, 46(2), 129-65, 2016年02月電子ジャーナル
  • Lymphocyte Antigen 75 Polymorphisms Are Associated with Disease Susceptibility and Phenotype in Japanese Patients with Inflammatory Bowel Disease.
    Hirayama A, Joshita S, Kitahara K, Mukawa K, Suga T, Umemura T, Tanaka E, Ota M
    Dis Markers, 2016, 6485343, 2016年
  • Insulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) as a Useful Immunohistochemical Marker for the Diagnosis of Adenocarcinoma of Small Intestine.
    Daikuhara S, Uehara T, Higuchi K, Hosaka N, Iwaya M, Maruyama Y, Matsuda K, Arakura N, Tanaka E, Ota H
    Acta Histochem Cytochem, 48(6), 193-204, 2015年12月電子ジャーナル
  • Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B.
    Matsumoto A, Yatsuhashi H, Nagaoka S, Suzuki Y, Hosaka T, Tsuge M, Chayama K, Kanda T, Yokosuka O, Nishiguchi S, Saito M, Miyase S, Kang JH, Shinkai N, Tanaka Y, Umemura T, Tanaka E
    Hepatol Res, 45(12), 1195-202, 2015年12月電子ジャーナル
  • A case of MUC5AC-positive intraductal neoplasm of the pancreas classified as an intraductal tubulopapillary neoplasm?
    Muraki T, Uehara T, Sano K, Oota H, Yoshizawa A, Asaka S, Tateishi A, Otsuki T, Shingu K, Matoba H, Kobayashi S, Ichimata S, Watanabe T, Itou T, Tanaka E
    Pathol Res Pract, 211(12), 1034-9, 2015年12月電子ジャーナル
  • Clinicopathological characterisation of duodenal adenocarcinoma with high CD44 variant 9 expression.
    Maruyama Y, Uehara T, Daikuhara S, Kobayashi Y, Nakajima T, Matsumoto A, Tanaka E, Ota H
    PATHOLOGY, 47(7), 647-52, 2015年12月電子ジャーナル
  • A case of acquired hemophilia A diagnosed after percutaneous endoscopic gastrostomy.
    Okamura T, Komatsu M, Ito A, Ito T, Suga T, Arakura N, Sakai H, Tanaka E
    Clin J Gastroenterol, 8(5), 290-3, 2015年10月電子ジャーナル
  • Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach.
    Yamada S, Okamura T, Kobayashi S, Tanaka E, Nakayama J
    J Gastroenterol Hepatol, 30(10), 1478-84, 2015年10月電子ジャーナル
  • Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study.
    Kusumoto S, Tanaka Y, Suzuki R, Watanabe T, Nakata M, Takasaki H, Fukushima N, Fukushima T, Moriuchi Y, Itoh K, Nosaka K, Choi I, Sawa M, Okamoto R, Tsujimura H, Uchida T, Suzuki S, Okamoto M, Takahashi T, Sugiura I, Onishi Y, Kohri M, et al
    Clin Infect Dis, 61(5), 719-29, 2015年09月電子ジャーナル
  • Primary hepatocellular carcinoma in a patient with neurofibromatosis type I.
    Kimura T, Tanaka N, Umemura T, Tanaka E
    Liver Int, 35(8), 2057-8, 2015年08月電子ジャーナル
  • Serum sodium concentration is associated with increased risk of mortality in patients with compensated liver cirrhosis.
    Umemura T, Shibata S, Sekiguchi T, Kitabatake H, Nozawa Y, Okuhara S, Kimura T, Morita S, Komatsu M, Matsumoto A, Tanaka E
    Hepatol Res, 45(7), 739-44, 2015年07月電子ジャーナル
  • Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis.
    Sekiguchi T, Umemura T, Fujimori N, Shibata S, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E, Ota M
    PLOS ONE, 10(6), e0131658, 2015年06月電子ジャーナル
  • Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis.
    Umemura T, Joshita S, Sekiguchi T, Usami Y, Shibata S, Kimura T, Komatsu M, Matsumoto A, Ota M, Tanaka E
    Am J Gastroenterol, 110(6), 857-64, 2015年06月電子ジャーナル
  • Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.
    Komatsu M, Kimura T, Yazaki M, Tanaka N, Yang Y, Nakajima T, Horiuchi A, Fang ZZ, Joshita S, Matsumoto A, Umemura T, Tanaka E, Gonzalez FJ, Ikeda S, Aoyama T
    Biochim Biophys Acta, 1852(3), 473-81, 2015年03月電子ジャーナル
  • Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy.
    Nagaya T, Tanaka N, Kimura T, Kitabatake H, Fujimori N, Komatsu M, Horiuchi A, Yamaura T, Umemura T, Sano K, Gonzalez FJ, Aoyama T, Tanaka E
    BBA Clin, 3, 168-74, 2015年02月電子ジャーナル
  • Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.
    Kamijo N, Matsumoto A, Umemura T, Shibata S, Ichikawa Y, Kimura T, Komatsu M, Tanaka E
    World J Gastroenterol, 21(2), 541-8, 2015年01月電子ジャーナル
  • Superficially located enlarged lymphoid follicles characterise nodular gastritis.
    Okamura T, Sakai Y, Hoshino H, Iwaya Y, Tanaka E, Kobayashi M
    PATHOLOGY, 47(1), 38-44, 2015年01月電子ジャーナル
  • Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan
    Umemura, T; Katsuyama, Y; Yoshizawa, K; Kimura, T; Joshita, S; Komatsu, M; Matsumoto, A; Tanaka, E; Ota, M
    PLOS ONE, 9(6), e100565, 2014年06月WebofScienceリポジトリ電子ジャーナル
  • Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B
    Tanaka, E; Matsumoto, A
    Hepatol Res, 44(1), 1-8, 2014年01月WebofScienceリポジトリ電子ジャーナル
  • STAT4 Gene Polymorphisms Are Associated with Susceptibility and ANA Status in Primary Biliary Cirrhosis
    Joshita, S; Umemura, T; Nakamura, M; Katsuyama, Y; Shibata, S; Kimura, T; Morita, S; Komatsu, M; Matsumoto, A; Yoshizawa, K; Ishibashi, H; Tanaka, E; Ota, M
    DISEASE MARKERS, 2014, 727393, 2014年WebofScienceリポジトリ電子ジャーナル
  • Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy
    Joshita, S; Shirahata, K; Yazaki, Y; Okaniwa, S; Nakamura, Y; Kimura, T; Noami, S; Horigome, R; Yagi, H; Ito, N; Yamazaki, A; Akahane, Y; Umemura, T; Yoshizawa, K; Tanaka, E; Ota, M
    HEPATOLOGY RESEARCH, 43(7), 801-807, 2013年07月WebofScienceリポジトリ電子ジャーナル
  • Comparison of carbon dioxide and air insufflation use by non-expert endoscopists during endoscopic retrograde cholangiopancreatography
    Muraki, T; Arakura, N; Kodama, R; Yoneda, S; Maruyama, M; Itou, T; Watanabe, T; Maruyama, M; Matsumoto, A; Kawa, S; Tanaka, E
    DIGESTIVE ENDOSCOPY, 25(2), 189-196, 2013年03月WebofScienceリポジトリ電子ジャーナル
  • Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis
    Morita, S; Joshita, S; Umemura, T; Katsuyama, Y; Kimura, T; Komatsu, M; Matsumoto, A; Yoshizawa, K; Kamijo, A; Yamamura, N; Tanaka, E; Ota, M
    HUMAN IMMUNOLOGY, 74(2), 219-222, 2013年02月WebofScienceリポジトリ電子ジャーナル
  • Liver Dysfunction and Thrombocytopenia Diagnosed as Intravascular Large B-cell Lymphoma Using a Timely and Accurate Transjugular Liver Biopsy
    Sekiguchi, N; Joshita, S; Yoshida, T; Kurozumi, M; Sano, K; Nakagawa, M; Ito, T; Matsushita, T; Komatsu, D; Komatsu, M; Ito, T; Umemura, T; Ikeda, S; Kadoya, M; Ishida, F; Tanaka, E
    INTERNAL MEDICINE, 52(17), 1903-1908, 2013年WebofScienceリポジトリ電子ジャーナル
  • Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection
    Matsumoto A, Tanaka E, Morita S, Yoshizawa K, Umemura T, Joshita S
    J Gastroenterol, 47(9), 1006-1013, 2012年09月
  • 2011 Japanese society for dialysis therapy guidelines for the treatment of hepatitis C virus infection in dialysis patients
    Akiba T, Hora K, Imawari M, Sato C, Tanaka E, Izumi N, Harada T, Ando R, Kikuchi K, Tomo T, Hirakata H, Akizawa T
    Ther Apher Dia, 16(4), 289-310, 2012年08月
  • Helicobacter pylori-Negative Primary Rectal MALT Lymphoma: Complete Remission after Radiotherapy
    Okamura T, Suga T, Iwaya Y, Ito T, Yokosawa S, Arakura N, Ota H, Tanaka E
    Case Rep Gastroenterol, 6(2), 319-27, 2012年07月
  • No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations
    Sawai H, Nishida N, Mbarek H, Matsuda K, Mawatari Y, Yamaoka M, Hige S, Kang J. H, Abe K, Mochida S, Watanabe M, Kurosaki M, Asahina Y, Izumi N, Honda M, Kaneko S, Tanaka E, Matsuura K, Itoh Y, Mita E, Korenaga M, Hino K, Murawaki Y, Hiasa Y, Ide T, Ito K, Sugiyama M, Ahn S. H, Han K. H, Park J. Y, Yuen M. F, Nakamura Y, Tanaka Y, Mizokami M, Tokunaga K
    BMC Med Genet, 13, 47, 2012年06月
  • Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean
    Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn S. H, Park J. Y, Hige S, Kang J. H, Suzuki K, Kurosaki M, Asahina Y, Mochida S, Watanabe M, Tanaka E, Honda M, Kaneko S, Orito E, Itoh Y, Mita E, Tamori A, Murawaki Y, Hiasa Y, Sakaida I, Korenaga M, Hino K, Ide T, Kawashima M, Mawatari Y, Sageshima M, Ogasawara Y, Koike A, Izumi N, Han KH, Tanaka Y, Tokunaga K, Mizokami M
    PLOS ONE, 7(6), e39175, 2012年06月
  • Hepatic Cerebroside Sulfotransferase Is Induced by PPARalpha Activation in Mice
    Kimura T, Nakajima T, Kamijo Y, Tanaka N, Wang L, Hara A, Sugiyama E, Tanaka E, Gonzalez Frank J, Aoyama T
    PPAR Res, 174932, 2012年05月
  • Risk of hepatitis B reactivation in patients treated with tumor necrosis factor-alpha inhibitors
    Tanaka E, Urata Y
    Hepatol Res, 42(4), 333-339, 2012年04月WebofScienceリポジトリ電子ジャーナル
  • Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection
    Joshita, Satoru; Umemura, Takeji; Katsuyama, Yoshihiko; Ichikawa, Yuki; Kimura, Takefumi; Morita, Susumu; Kamijo, Atsushi; Komatsu, Michiharu; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Kamijo, Nozomi; Ota, Masao; Tanaka, Eiji
    HUMAN IMMUNOLOGY, 73(3), 298-300, 2012年03月WebofScienceリポジトリ電子ジャーナル
  • Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B
    Matsumoto A, Tanaka E, Suzuki Y, Kobayashi M, Tanaka Y, Shinkai N, Hige S, Yatsuhashi H, Nagaoka S, Chayama K, Tsuge M, Yokosuka O, Imazeki F, Nishiguchi S, Saito M, Fujiwara K, Torii N, Hiramatsu N, Karino Y, Kumada H
    Hepatol Res, 42(2), 139-149, 2012年02月
  • Long-term outcome of japanese patients with type 1 autoimmune hepatitis
    Yoshizawa K, Matsumoto A, Ichijo T, Umemura T, Joshita S, Komatsu M, Tanaka N, Tanaka E, Ota M, Katsuyama Y, Kiyosawa K, Abe M, Onji M
    56(2), 668-676, 2012年02月
  • Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis
    Umemura T, Joshita S, Ichijo T, Yoshizawa K, Katsuyama Y, Tanaka E
    Hepatology, 55(2), 506-511, 2012年02月WebofScienceリポジトリ電子ジャーナル
  • Assessment of safety of using antithrombotic agents during esophagogastroduodenoscopy: rationale and design of the ASAMA Study
    Kasai H, Suga T, Ikeda U, Yoshioka J, Tanaka E, Akamatsu T, for the ASAMA study Investigators
    Shinshu Medical Journal, 60(3), 143-148, 2012年リポジトリ
  • Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening.
    Akamatsu T, Ichikawa S, Okudaira S, Yokosawa S, Iwaya Y, Suga T, Ota H, Tanaka E
    J Gastroenterol, 46(12), 1353-1360, 2011年12月電子ジャーナル
  • Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients
    Aiba Y, Nakamura M, Joshita S, Inamine T, Komori A, Yoshizawa K, Umemura T, Horie H, Migita K, Yatsuhashi H, Nakamuta M, Fukushima N, Saoshiro T, Hayashi S, Kouno H, Ota H, Muro T, Watanabe Y, Nakamura Y, Komeda T, Shimada M, Masaki N, Komatsu T, Yagura M, Sugi K, Koga M, Tsukamoto K, Tanaka E, Ishibashi H, P. B. C. Study Group in NHOSLJ
    J Gastroenterol, 46(10), 1203-1212, 2011年10月
  • Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C.
    Umemura T, Joshita S, Yoneda S, Katsuyama Y, Ichijo T, Matsumoto A, Yoshizawa K, Ota M, Tanaka E
    Antivir Ther, 16(7), 1073-1080, 2011年10月WebofScienceリポジトリ電子ジャーナル
  • Primary gastric diffuse large B-cell lymphoma with orbital involvement: diagnostic usefulness of 18F-fluorodeoxyglucose positron emission tomography.
    Iwaya Y, Takenaka K, Akamatsu T, Yamada Y, Haba S, Matsuda K, Nakazawa H, Muraki T, Kaneko Y, Ito T, Sano K, Arakura N, Tanaka E, Ishida F
    Intern Med, 50(18), 1953-1956, 2011年09月
  • Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C
    Tanaka Y, Kurosaki M, Nishida N, Sugiyama M, Matsuura K, Sakamoto N, Enomoto N, Yatsuhashi H, Nishiguchi S, Hino K, Hige S, Itoh Y, Tanaka E, Mochida S, Honda M, Hiasa Y, Koike A, Sugauchi F, Kaneko S, Izumi N, Tokunaga K, Mizokami M
    HUMAN MOLECULAR GENETICS, 20(17), 3507-3516, 2011年09月WebofScience電子ジャーナル
  • Early detection of interstitial pneumonia by monitoring KL-6 in a chronic hepatitis C patient undergoing pegylated interferon and ribavirin therapy
    Ichikawa-Yamada Y, Joshita S, Tsukahara Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E
    HEPATOLOGY RESEARCH, 41(9), 904-909, 2011年09月WebofScienceリポジトリ電子ジャーナル
  • Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy
    Tanaka N, Horiuchi A, Yokoyama T, Kaneko G, Horigome N, Yamaura T, Nagaya T, Komatsu M, Sano K, Miyagawa S, Aoyama T, Tanaka E
    JOURNAL OF GASTROENTEROLOGY, 46(6), 758-768, 2011年06月WebofScience電子ジャーナル
  • Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C
    Yoneda S, Umemura T, Joshita S, Ichijo T,Matsumoto A, Yoshizawa K, Katsuyama Y, Ota M, Tanaka E
    HEPATOLOGY RESEARCH, 41(6), 587-593, 2011年06月WebofScienceリポジトリ電子ジャーナル
  • Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b
    Sakamoto N, Nakagawa M, Tanaka Y, Sekine-Osajima Y, Ueyama M, Kurosaki M, Nishida N, Tamori A, Yuki NS, Itsui Y, Azuma S, Kakinuma S, Hige S, Itoh Y, Tanaka E, Hiasa Y, Izumi N, Tokunaga K, Mizokami M, Watanabe M
    JOURNAL OF MEDICAL VIROLOGY, 83(5), 871-878, 2011年05月WebofScience電子ジャーナル
  • Cytokine profiles affecting the pathogenesis of autoimmune hepatitis in Japanese patients
    Kamijo A, Yoshizawa K, Joshita S, Yoneda S, Umemura T, Ichijo T, Matsumoto A, Ota M, Tanaka E
    HEPATOLOGY RESEARCH, 41(4), 350-357, 2011年04月WebofScience電子ジャーナル
  • Association of Serum Cytokine Levels With Treatment Response to Pegylated Interferon and Ribavirin Therapy in Genotype 1 Chronic Hepatitis C Patients
    Yoneda, Suguru; Umemura, Takeji; Katsuyama, Yoshihiko; Kamijo, Atsushi; Joshita, Satoru; Komatsu, Michiharu; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Ota, Masao; Tanaka, Eiji
    JOURNAL OF INFECTIOUS DISEASES, 203(8), 1087-1095, 2011年04月WebofScienceリポジトリ電子ジャーナル
  • Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009
    Yokosuka O, Kurosaki M, Imazeki F, Arase Y, Tanaka Y, Chayama K, Tanaka E, Kumada H, Izumi N, Mizokami M, Kudo M
    HEPATOLOGY RESEARCH, 41(1), 1-21, 2011年01月WebofScience電子ジャーナル
  • Clinical significance of immunoglobulin G4-associated autoimmune hepatitis
    Umemura T, Zen Y, Hamano H, Joshita S, Ichijo T, Yoshizawa K, Kiyosawa K, Ota M, Kawa S, Nakanuma Y, Tanaka E
    JOURNAL OF GASTROENTEROLOGY, 46(SUPPL 1), 48-55, 2011年01月WebofScienceリポジトリ電子ジャーナル
  • A Case of Pyogenic Liver Abscess Infected with Fusobacterium necrophorum Depicted by Microscopy and Confirmed by Tissue Culture
    Nozawa Y, Joshita S, Fukushima M, Sugiyama Y, Ichikawa Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E
    INTERNAL MEDICINE, 50(17), 1815-1819, 2011年WebofScienceリポジトリ電子ジャーナル
  • Severe hepatic encephalopathy and decrease in enhancement of hepatocellular carcinoma treated with sorafenib
    Kimura T, Umemura T, Ichijo T, Yamamura N, Tanaka E
    International Journal of Case Reports and Images, 1(4), 16-18, 2010年12月
  • Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease
    Hatta T, Fujinaga Y, Kadoya M, Ueda H, Murayama H, Kurozumi M, Ueda K, Komatsu M, Nagaya T, Joshita S, Kodama R, Tanaka E, Uehara T, Sano K, Tanaka N
    JOURNAL OF GASTROENTEROLOGY, 45(12), 1263-1271, 2010年12月WebofScienceリポジトリ電子ジャーナル
  • Small bowel tissue concentration of rebamipide: study of two dosages in healthy subjects
    Akamatsu T, Nagaya T, Ichikawa S, Sudo T, Takeda R, Takenaka K, Kodama R, Ito T, Arakura N, Tanaka E
    Journal of Clinical Biochemistry and Nutrition, 47(3), 256-260, 2010年11月WebofScience
  • Eicosapentaenoic acid improves hepatic steatosis independent of PPARalpha activation through inhibition of SREBP-1 maturation in mice
    Tanaka N, Zhang X, Sugiyama E, Kono H, Horiuchi A, Nakajima T, Kanbe H, Tanaka E, Gonzalez FJ, Aoyama T
    Biochemical Pharmacology, 80(10), 1601-1612, 2010年11月WebofScience電子ジャーナル
  • Down-regulation of SREBP-1c is associated with the development of burned-out NASH
    Nagaya T, Tanaka N, Suzuki T, Sano K, Horiuchi A, Komatsu M, Nakajima T, Nishizawa T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Nakayama J, Tanaka E, Aoyama T
    JOURNAL OF HEPATOLOGY, 53(4), 724-731, 2010年10月WebofScience
  • Chronic gastritis in the setting of autoimmune pancreatitis
    Uehara T, Hamano H, Kawa S, Sano K, Oki K, Kobayashi Y, Nagaya T, Akamatsu T, Kurozumi M, Fujinaga Y, Tanaka E, Honda T, Ota H
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 34(9), 1241-1249, 2010年09月WebofScience電子ジャーナル
  • Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients
    Joshita, Satoru; Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Nakamura, Minoru; Ishibashi, Hiromi; Ota, Masao
    JOURNAL OF HEPATOLOGY, 53(3), 537-541, 2010年09月WebofScienceリポジトリ電子ジャーナル
  • Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment
    Tamura Y, Igarashi M, Suda T, Wakai T, Shirai Y, Umemura T, Tanaka E, Kakizaki S, Takagi H, Hiasa Y, Onji M, Aoyagi Y
    DIGESTIVE DISEASES AND SCIENCES, 55(7), 2095-2101, 2010年07月WebofScience電子ジャーナル
  • Effect of bezafibrate on hepatic oxidative stress: comparison between conventional experimental doses and clinically-relevant doses in mice.
    Nakajima T, Tanaka N, Li G, Hu R, Kamijo Y, Hara A, Aoyama T
    Redox Rep, 15(3), 123-130, 2010年07月電子ジャーナル
  • Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels
    Tsutsui, Masaru; Tanaka, Naoki; Kawakubo, Masatomo; Sheena, Yo; Horiuchi, Akira; Komatsu, Michiharu; Nagaya, Tadanobu; Joshita, Satoru; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Aoyama, Toshifumi; Tanaka, Eiji; Sano, Kenji
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 44(6), 440-447, 2010年07月WebofScienceリポジトリ電子ジャーナル
  • Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits
    Tsuruta, Goro; Tanaka, Naoki; Hongo, Minoru; Komatsu, Michiharu; Horiuchi, Akira; Hamamoto, Kaeko; Iguchi, Chieko; Nakayama, Yoshiko; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Aoyama, Toshifumi; Tanaka, Eiji
    JOURNAL OF GASTROENTEROLOGY, 45(6), 666-672, 2010年06月WebofScienceリポジトリ電子ジャーナル
  • A2BP1 as a novel susceptible gene for primary biliary cirrhosis in Japanese patients
    Joshita, Satoru; Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Ota, Masao
    HUMAN IMMUNOLOGY, 71(5), 520-524, 2010年05月WebofScienceリポジトリ電子ジャーナル
  • A Case of Granulocyte-Colony Stimulating Factor-Producing Hepatocellular Carcinoma Confirmed by Immunohistochemistry
    Joshita, Satoru; Nakazawa, Koh; Koike, Shoichiro; Kamijo, Atsushi; Matsubayashi, Kiyoshi; Miyabayashi, Hideharu; Furuta, Kiyoshi; Kitano, Kiyoshi; Yoshizawa, Kaname; Tanaka, Eiji
    JOURNAL OF KOREAN MEDICAL SCIENCE, 25(3), 476-480, 2010年03月WebofScienceリポジトリ電子ジャーナル
  • Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
    Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y
    HEPATOLOGY RESEARCH, 40(1), 8-13, 2010年01月WebofScience電子ジャーナル
  • Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
    Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y
    HEPATOLOGY RESEARCH, 40(1), 1-7, 2010年01月WebofScience電子ジャーナル
  • Usefulness of double balloon enteroscopy and video capsule endoscopy for the diagnosis and management of primary follicular lymphoma of the gastrointestinal tract in its early stages
    Akamatsu T, Kaneko Y, Ota H, Miyabayashi H, Arakura N, Tanaka E
    DIGESTIVE ENDOSCOPY, 22(1), 33-38, 2010年01月WebofScience電子ジャーナル
  • A Patient with Advanced Hepatocellular Carcinoma Treated with Sorafenib Tosylate Showed Massive Tumor Lysis with Avoidance of Tumor Lysis syndrome
    Joshita, Satoru; Yoshizawa, Kaname; Sano, Kenji; Kobayashi, Satoshi; Sekiguchi, Tomohiro; Morita, Susumu; Kamijo, Atsushi;Komatsu, Michiharu; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Tanaka, Eiji
    INTERNAL MEDICINE, 49(11), 991-994, 2010年WebofScienceリポジトリ電子ジャーナル
  • CLINICAL AND VIROLOGICAL FEATURES OF PATIENTS WITH FULMINANT HEPATIC FAILURE DUE TO HEPATITIS B VIRUS REACTIVATION FROM HBSAG-NEGATIVE STATUS
    Umemura, T.; Kiyosawa, K.; Tanaka, E.; Grp, Japan Novo Hepatitis B. Res
    JOURNAL OF HEPATOLOGY, 52(Suppl. 1), S286-S286, 2010年WebofScienceリポジトリ電子ジャーナル
  • Down-regulation of SREBP-1c is associated with the development of burned-out NASH
    Nagaya, T.; Tanaka, N.; Komatsu, M.; Joshita, S.; Umemura, T.; Ichijo, T.; Matsumoto, A.; Yoshizawa, K.; Aoyama, T.; Tanaka, E.
    JOURNAL OF HEPATOLOGY, 52(Suppl. 1), S373-S374, 2010年WebofScienceリポジトリ電子ジャーナル
  • Comparison of hepatitis B virus DNA, RNA, and core related antigen as predictors of lamivudine resistance in patients with chronic hepatitis B
    Matsumoto A, Maki N, Yoshizawa K, Umemura T, Joshita S, Tanaka E
    ShinshuMed J, 58(4), 153-162, 2010年リポジトリ
  • Combination Chemotherapy with Low-dose 5-FU, Cisplatin, and Gemcitabine for Gemcitabine-Refractory Pancreatic Cancer
    Norikazu ARAKURA, Osamu HASEBE, Yasuhide OCHI, Hideaki HAMANO, Eiji TANAKA, Shigeyuki KAWA
    信州医学雑誌, 57(6), 247-253, 2009年12月リポジトリ
  • Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study
    Okanoue, Takeshi; Itoh, Yoshito; Hashimoto, Hiroaki; Yasui, Kohichiroh; Minami, Masahito; Takehara, Tetsuo; Tanaka, Eiji; Onji, Morikazu; Toyota, Joji; Chayama, Kazuaki; Yoshioka, Kentaro; Izumi, Namiki; Akuta, Norio; Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY, 44(9), 952-963, 2009年09月WebofScience電子ジャーナル
  • A case of well-differentiated cholangiolocellular carcinoma visualizedwith contrast-enhanced ultrasonography using Sonazoid
    Joshita, Satoru; Ichijo, Tetsuya; Suzuki, Fumitaka; Yokoyama, Takahide; Sugiyama, Yukiko; Fukushima, Mana; Kamijo, Atsushi; Komatsu, Michiharu; Umemura, Takeji; Yoshizawa, Kaname; Miyagawa, Shinichi; Tanaka, Eiji
    HEPATOLOGY RESEARCH, 39(2), 207-212, 2009年02月WebofScienceリポジトリ電子ジャーナル
  • Abscess of the Round Ligament of the Liver Associated with Acute Obstructive Cholangitis and Septic Thrombosis
    Arakura, Norikazu; Ozaki, Yayoi; Yamazaki, Sachie; Ueda, Kazuhiko; Maruyama, Masafumi; Chou, Yoshimi; Kodama, Ryo; Takayama, Mari; Hamano, Hideaki; Tanaka, Eiji; Kawa, Shigeyuki
    INTERNAL MEDICINE, 48(21), 1885-1888, 2009年WebofScienceリポジトリ電子ジャーナル
  • Primitive Neuroectodermal Tumor as a Differential Diagnosis of CD56-Positive Tumors in Adults
    Nagaya, Tadanobu; Tanaka, Naoki; Kamijo, Atsushi; Joshita, Satoru; Nakazawa, Koh; Miyabayashi, Hideharu; Yoneda, Suguru; Ito, Tetsuya; Komatsu, Michiharu; Tanaka, Eiji; Kitano, Kiyoshi
    INTERNAL MEDICINE, 48(15), 1267-1272, 2009年WebofScienceリポジトリ電子ジャーナル
  • Pancreaticobiliary Fistula Evident after ESWL Treatment of Pancreatolithiasis
    Arakura, N; Ozaki, Y; Maruyama, M; Chou, Y; Kodama, R; Takayama, M; Hamano, H; Tanaka, E; Kawa, S
    INTERNAL MEDICINE, 48(7), 545-549, 2009年WebofScienceリポジトリ電子ジャーナル
  • Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis
    Tanaka, N; Sano, K; Horiuchi, A; Tanaka, E; Kiyosawa, K; Aoyama, T
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 42(4), 413-418, 2008年WebofScienceリポジトリ
  • Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan
    Umemura, T; Tanaka, E; Kiyosawa, K; Kumada, H
    CLINICAL INFECTIOUS DISEASES, 47(5), E52-E56, 2008年WebofScienceリポジトリ電子ジャーナル
  • Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase
    Tanaka, N; Nagaya, T; Komatsu, M; Horiuchi, A; Tsuruta, G; Shirakawa, H; Umemura, T; Ichijo, T; Matsumoto, A; Yoshizawa, K; Aoyama, T; Kiyosawa, K; Tanaka, E
    LIVER INTERNATIONAL, 28(8), 1104-1111, 2008年WebofScienceリポジトリ電子ジャーナル
  • Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C
    Umemura, T; Muto, H; Tanaka, E; Matsumoto, A; Ichijo, T; Yoshizawa, K; Akamatsu, T; Kiyosawa, K
    JOURNAL OF VIRAL HEPATITIS, 14(1), 48-54, 2007年WebofScienceリポジトリ電子ジャーナル
  • Lack of association between FCRL3 and Fc gamma RII polymorphisms in Japanese type 1 autoimmune hepatitis
    Umemura, T; Ota, M; Yoshizawa, K; Katsuyama, Y; Ichijo, T; Tanaka, E; Kawa, S; Kiyosawa, K
    Clinical Immunology, 122(3), 338-342, 2007年WebofScienceリポジトリ電子ジャーナル
  • Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
    Sugauchi, F; Orito, E; Ohno, T; Tanaka, Y; Ozasa, A; Kang, JH; Toyoda, J; Kuramitsu, T; Suzuki, K; Tanaka, E; Akahane, Y; Ichida, T; Izumi, N; Inoue, K; Hoshino, H; Iino, S; Yotsuyanagi, H; Kakumu, S; Tomita, E; Okanoue, T; Nishiguchi, S; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sata, M; Miyakawa, Y; Ueda, R; Mizokami, M
    HEPATOLOGY RESEARCH, 36(2), 107-114, 2006年WebofScience
  • A genome-wide DNA microsatellite association study of autoimmune hepatitis type 1 in Japan
    Yoshizawa, K; Yokosawa, S; Ota, M; Katsuyama, Y; Ichijo, T; Umemura, T; Matsumoto, A; Tanaka, E; Kiyosawa, K
    Hepatology, 44(4), 228A-228A, 2006年WebofScience
  • Influence of hepatitis B virus genotypes as well as precore and core-promoter mutations on fulminant outcome of acute infection
    Sugauchi, F; Orito, E; Tanaka, Y; Ozasa, A; Kang, JH; Toyoda, J; Yotsuyanagi, H; Iino, S; Kuramitsu, T; Suzuki, K; Tanaka, E; Akahane, Y; Izumi, N; Inoue, K; Kakumu, S; Tomita, E; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sata, M; Okanoue, T; Nishiguchi, S; Miyakawa,Y; Mizokami, M
    Hepatology, 44(4), 539A-539A, 2006年WebofScience
  • Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection
    Ozasa, A; Tanaka, Y; Orito, E; Sugiyama, M; Kang, JH; Hige, S; Kuramitsu, T; Suzuki, K; Tanaka, E; Okada, S; Tokita, H; Asahina, Y; Inoue, K; Kakumu, S; Okanoue, T; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sakugawa, H; Miyakawa, Y; Ueda, R; Mizokami, M
    Hepatology, 44(2), 326-334, 2006年WebofScience
  • Timing of interferon therapy and sources of infection in patients with acute hepatitis C
    Ogata, K; Ide, T; Kumashiro, R; Kumada, H; Yotsuyanagi, H; Okita, K; Akahane, Y; Kaneko, S; Tsubouchi, H;Tanaka, E; Moriwaki, H; Nishiguchi, S; Kakumu, S; Mizokami, M; Iino, S; Sata, M
    HEPATOLOGY RESEARCH, 34(1), 35-40, 2006年WebofScience
  • Hepatitis B virus RNA is measurable in serum and can be a new marker for monitoring lamivudine therapy
    Rokuhara, A; Matsumoto, A; Tanaka, E; Umemura, T; Yoshizawa, K; Kimura, T; Maki, N; Kiyosawa, K
    JOURNAL OF GASTROENTEROLOGY, 41(8), 785-790, 2006年WebofScienceリポジトリ電子ジャーナル
  • Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population
    Tanaka, N; Tanaka, E; Sheena, Y; Komatsu, M; Okiyama, W; Misawa, N; Muto, H; Umemura, T; Ichijo, T; Matsumoto, A; Yoshizawa, K; Horiuchi, A; Kiyosawa, K
    LIVER INTERNATIONAL, 26(8), 956-963, 2006年WebofScienceリポジトリ電子ジャーナル
  • Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region
    Kitano, K; Kobayashi, H; Hanamura, M; Furuta, K; Ueno, M; Rokuhara, A; Tanaka, E; Umemura, T; Kiyosawa, K
    EUROPEAN JOURNAL OF HAEMATOLOGY, 77(3), 255-258, 2006年WebofScienceリポジトリ電子ジャーナル
  • Laparoscopic findings in patients with nonalcoholic steatohepatitis
    Tanaka, N; Ichijo, T; Okiyama, W; Mutou, H; Misawa, N; Matsumoto, A; Yoshizawa, K; Tanaka, E; Kiyosawa, K
    LIVER INTERNATIONAL, 26(1), 32-38, 2006年WebofScienceリポジトリ電子ジャーナル
  • Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance
    Tanaka, E; Matsumoto, A; Suzuki, F; Kobayashi, M;Mizokami, M; Tanaka, Y; Okanoue, T; Minami, M; Chayama, K; Imamura, M; Yatsuhashi, H; Nagaoka, S; Yotsuyanagi, H; Kawata, S; Kimura, T; Maki, N; Iino, S; Kiyosawa, K
    LIVER INTERNATIONAL, 26(1), 90-96, 2006年WebofScienceリポジトリ電子ジャーナル
  • Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics
    Misawa, N; Matsumoto, A; Tanaka, E; Rokuhara, A; Yoshizawa, K; Umemura, T; Maki, N; Kimura, T; Kiyosawa, K
    JOURNAL OF MEDICAL VIROLOGY, 78(1), 68-73, 2006年WebofScienceリポジトリ電子ジャーナル
  • Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma
    Gad A, Tanaka E, Matsumoto A, Wahab MA, Serwah Ael-H, Attia F, Ali K, Hassouba H, el-Deeb Ael-R, Ichijyo T, Umemura T, Muto H, Yoshizawa K, Kiyosawa K
    WorldJ Gastroenterol, 14, 6607-6612, 2005年
  • Ethnicity affects the diagnostic validity of alpha-fetoprotein in hepatocellular carcinoma
    Gad A, Tanaka E, Matsumoto A, Serwah Ael-H , Attia F , Hassan A, Ali K , Abbas A, el-Deeb Ael- , Sun X, Umemura T, Ichijyo T, Ehara T, Yoshizawa K, Kiyosawa K
    Asia-Pacific Journal of clinical oncology, 1, 64-70, 2005年
  • 当科における肝細胞癌に対するラジオ波焼灼術の実態
    一條哲也,沖山 洋,武藤英知,三沢倫子,梅村武司,松本晶博,吉澤 要,田中榮司,清澤研道
    長野県医学会雑誌, 35, 38-39, 2005年
  • 信州大学病院において-ウィルス性肝炎移植の現状と問題点-
    田中榮司
    今日の移植, 18, 216-219, 2005年
  • E型肝炎ウィルス(HEV)マーカー 広範囲血液・尿化学検査,免疫学的検査
    田中榮司
    日本臨床, 63, 421-423, 2005年
  • 【生活習慣病と非アルコール性脂肪肝炎(NASH)】脂肪肝と肝移植
    田中直樹,田中榮司,清澤研道
    Progress inMedicine, 25, 1657-1660, 2005年
  • 【C型肝炎の最新治療 治療方針のたて方と治療効果】治療方針とその効果 高ウイルス量の患者への治療方針と効果
    松本晶博,田中榮司,清澤研道
    消化器の臨床, 8, 180-183, 2005年
  • ウィルス性肝炎の治療の最前線
    四柳 宏,田中榮司,横須賀 収
    ヒューマンサイエンス, 16, 4-10, 2005年
  • Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients
    Yagi S, Mori K, Tanaka E, Matsumoto A, Sunaga F, Kiyosawa K, Yamaguchi K
    J Med Virol, 77(3), 399-413, 2005年WebofScience
  • Identification and quantitative analysis of a 22-KDA precore protein lacking C-terminal arginine-rich domain in hepatitis B virus DNA-negative Dane particles.
    Kimura, T; Ohue, C; Ohno, N; Terada, N; Ohno, S; Akinori, R; Matsumoto, A; Tanaka, E; Kiyosawa, K; Maki, N
    Hepatology, 42(4), 708A-708A, 2005年WebofScience
  • Differences of hepatocellular carcinoma patients with hepatitis B virus genotypes of Ba, Bj or C in Japan
    Orito, E; Sugauchi, F; Tanaka, Y; Ichida, T; Sata, M; Tanaka, E; Okanoue, T; Sakugawa, H; Watanabe, H; Miyakawa, H; Nishiguchi, S; Kumada, H; Ueda, R; Mizokami, M
    INTERVIROLOGY, 48(4), 239-245, 2005年WebofScience
  • Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection
    Higashi, K; Tsukiyama-Kohara, K; Tanaka, T; Tanaka, E; Kiyosawa, K; Kohara, M
    ARCHIVES OF VIROLOGY, 150(5), 883-898, 2005年WebofScience
  • Hepatitis B virus core and core-related antigen quantitation in Chinese patients with chronic genotype B and C hepatitis B virus infection
    Rokuhara A, Sun X, Tanaka E, Kimura T, Matsumoto A, Yao D, Yin L, Wang N, Maki N, Kiyosawa K
    J Gastroenterol Hepatol, 20(11), 1726-1730, 2005年WebofScienceリポジトリ電子ジャーナル
  • Nucleotide mutations associated with hepatitis B e antigen negativity
    Sun X, Rokuhara A, Tanaka E, Gad A, Mutou H, Matsumoto A, Yoshizawa K, Kiyosawa K
    J Med Virol, 76(2), 170-175, 2005年WebofScienceリポジトリ電子ジャーナル
  • Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis
    Yoshizawa K, Ota M, Katsuyama Y, Ichijo T, Matsumoto A, Tanaka E, Kiyosawa K
    J Hepatol, 42(4), 578-584, 2005年WebofScienceリポジトリ電子ジャーナル
  • Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients
    Matsumoto, A; Tanaka, E; Rokuhara, A; Kiyosawa, K; Kumada, H; Omata, M; Okita, K; Hayashi, N; Okanoue, T; Iino, S; Tanikawa, K
    HEPATOLOGY RESEARCH, 32(3), 173-184, 2005年WebofScienceリポジトリ電子ジャーナル
  • Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan
    Tanaka, E; Matsumoto, A; Takeda, N; Li, TC; Umemura, T; Yoshizawa, K; Miyakawa, Y; Miyamura, T; Kiyosawa, K
    JOURNAL OF VIRAL HEPATITIS, 12(4), 439-442, 2005年WebofScienceリポジトリ電子ジャーナル
  • Hepatitis B virus DNA-negative Dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain
    Kimura, T; Ohno, N; Terada, N; Rokuhara, A; Matsumoto, A; Yagi, S; Tanaka, E; Kiyosawa, K; Ohno, S; Maki, N
    JOURNAL OF BIOLOGICAL CHEMISTRY, 280(23), 21713-21719, 2005年WebofScienceリポジトリ電子ジャーナル
  • Wilson病の治療と発症予防
    梅村武司,田中栄司,清澤研道
    肝臓, 45, 459-462, 2004年
  • SENウイルス(SEN V)の分子生物学
    梅村武司,田中栄司
    日本臨床, 62, 596-597, 2004年
  • 我が国におけるSENウイルス感染の状況とその背景
    梅村武司,田中栄司
    日本臨床, 62, 602-605, 2004年
  • C型肝炎ウイルス 特殊型C型肝炎の臨床特論 HCV,HGV重複感染の疫学
    折井幸司,田中栄司,清澤研道
    日本臨床, 62, 677-681, 2004年
  • B型肝炎の治療 B型肝炎診療Q&A HBe抗原陽性,高ウイルス量のB型慢性肝炎症例にいかに対処するか
    田中栄司
    臨床医, 30, 1601-1603, 2004年
  • B型慢性肝炎 HBe抗原陰性,肝機能異常を繰り返す症例に対する冶療
    田中栄司
    肝臓, 45, 397-401, 2004年
  • C型肝炎 最近の動向
    田中栄司
    看護技術, 50, 11-15, 2004年
  • C型肝炎ウイルス(HCV) HCV抗原測定法 HCVコア抗原測定法とその臨床的有用性
    田中栄司
    日本臨床, 62, 208-213, 2004年
  • E型肝炎の概論
    田中栄司
    日本臨床, 62, 536-541, 2004年
  • B型肝炎の治療up to date ラミブジン治療は肝発癌過程を修飾するか
    松本晶博,田中栄司,清澤研道
    臨床消化器内科, 191, 1507-1512, 2004年
  • C型肝炎ウイルス(HCV) C型慢性肝炎 予後に関連する因子の解析臨床検査データ
    松本晶博,田中栄司,清澤研道
    日本臨床, 62, 430-433, 2004年
  • Hepatitis B virus covalently closed circuler DNAの定療法と臨床的意義
    向出雅一,松本晶博,六波羅明紀,田中栄司,竹村一男,兒崎隆純,引地一昌,清澤研道
    SRL宝函, 28, 175-179, 2004年
  • C型肝硬変.血小板滅少例(血小板数58000~85000/μ 1)に対する少量INF-β療法の治療成績
    山浦高裕,一條哲也,海野 洋,岡庭信司,中村喜行,太田裕志,松尾恭介,六波羅明紀,松本晶博,吉澤 要,田中栄司,清澤研道
    飯田市立病院医誌, 10, 21-24, 2004年
  • Peroxisome proliferator-activated receptor a protects against alcohol-induced liver damage
    Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, TanakaE, Kiyosawa K, Fukushima Y, Peters JM, Gonzalez FJ, Aoyama T
    Hepatology, 40(4), 972-980, 2004年WebofScience
  • Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting abiochemical response
    Imai Y, Kasahara A, Tanaka H, Okanoue T, Hiramatsu N, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Sasaki Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N
    J Gastroenterol, 39(11), 1069-1077, 2004年WebofScience
  • Inteferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death
    Kasahara A, Tanaka H, Okanoue T, Imai Y, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N
    J ViralHepat, 11(2), 148-156, 2004年WebofScience
  • Hepatocellular carcinoma: recent trends in Japan
    Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E
    Gastroenteroiogy, 127(5), S17-S26, 2004年WebofScience
  • Nagano Interferon Treatment Research Group: Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C:analysis by a prospective study
    Muto H, Tanaka E, Matsumoto A, Yoshizawa K, Kiyosawa K
    J Gastroenterol, 39(7), 674-680, 2004年WebofScience
  • Ribavirin-induced pure red-cell aplasia during treatment of chronic hepatitis C
    Tanaka .N, Ishida F, Tanaka E
    N Engl J Med, 350(12), 1264-1265, 2004年WebofScience
  • Hepatic hydrothorax in the absence of ascites diagnosed by intraperitoneal spraying of indocyanine green
    Umino J, Tanaka E, Ichijoh T, Muraki T, Orii K, Yoshizawa K, Kiyosawa K
    Intem Med, 43(4), 283-288, 2004年WebofScience
  • Hepatitis B virus genotype G is an extremely rare genotype in Japan
    Kato, H; Sugauchi, F; Ozasa, A; Kato, T; Tanaka, Y; Sakugawa, H; Sata, M; Hino, K; Onji, M; Okanoue, T; Tanaka, E; Kawata, S; Suzuki, K; Hige, S; Ohno, T; Orito, E; Ueda, R; Mizokami, M
    HEPATOLOGY RESEARCH, 30(4), 199-203, 2004年WebofScience
  • その他のウイルスによる肝炎
    梅村武司,田中榮司
    臨床医, 29, 645-647, 2003年
  • 成人生体肝移植・ウイルス肝炎術後再発 予防と治療
    清澤研道,田中榮司
    今日の移植, 16, 473-478, 2003年
  • C型肝炎診断の新展開
    田中榮司
    Medical Technology, 31, 138-144, 2003年
  • NASHの成因と病態 肝炎ウイルスとNASH
    田中直樹,田中榮司,清澤研道
    臨床消化器内科, 18, 1269-1274, 2003年
  • Crohn病の良性狭窄病変に対する内視鏡的バルーン拡張術の検討
    村木 崇,赤松泰次,横澤秀一,三澤倫子,立岩伸之,進士明宏,小松健一,川村葉子,高山真理,浜野英明,越知泰英,中村 直,吉澤 要,田中榮司,清澤研道
    ENDOSCOPIC FORUM for digestive disease, 19, 167-173, 2003年
  • B型慢性肝炎に対するラミブジン治療のウイルス学的効果予測式の作成
    六波羅明紀,松本晶博,武藤英知,沖山 洋,田中直樹,丸山敦史,山浦高裕,折井幸司,一條哲也,吉澤 要,小林正和,袖山 健,田中榮司,清澤研道
    肝臓, 44, 182-183, 2003年
  • Clinical significance of SEN virus infection in patients on maintenance haemodialysis
    Kobayashi N, Tanaka E, Umemura T, Matsumoto A, Iijima T, Higuchi M, Hora K, Kiyosawa K
    Nephrol Dial Transplant, 18(2), 348-352, 2003年WebofScience
  • Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: ethnic and genotypic influence
    Gad A, Tanaka E, Matsumoto A, el-Hamid Serwah A, Ali K, Makledy F, el-Gohary A, Orii K, Ijima A, Rokuhara A, Yoshizawa K, Nooman Z, Kiyosawa K
    J Med Virol, 70(4), 594-599, 2003年WebofScience
  • New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA
    Kimura T, Rokuhara A, Matsumoto A, Yagi S, Tanaka E, Kiyosawa K, Maki N
    J Clin Microbiol, 41(5), 1901-1906, 2003年WebofScience
  • Seroepidemiology of Helicobacter pylori and hepatitis A virus and the mode of transmission of infection: a 9-year cohort study in rural Japan
    Malaty HM, Tanaka E, Kumagai T, Ota H, Kiyosawa K, Graham DY, Katsuyama T
    Clin Infect Dis, 37(8), 1067-1072, 2003年WebofScience
  • Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment
    Rokuhara A, Tanaka E, Matsumoto A, Kimura T, Yamaura T, Orii K, Sun X, Yagi S, Maki N, Kiyosawa K
    J Viral Hepat, 10(4), 324-330, 2003年WebofScience
  • Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis
    Umemura T, Tanaka E, Ostapowicz G, Brown KE, Heringlake S, Tassopoulos NC, Wang RY, Yeo AE, Shih JW, Orii K, Young NS, Hatzakis A, Manns MP, Lee WM, Kiyosawa K, Alter HJ
    J Infect Dis, 188(10), 1545-1552, 2003年WebofScience
  • A case-control study for early prediction ofhepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter
    Yamaura T, Tanaka E, Matsumoto A, Rokuhara A, Orii K, Yoshizawa K, Miyakawa Y, Kiyosawa K
    J Med Virol, 70(4), 545-552, 2003年WebofScience
  • Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease
    Yoshizawa K, Ota M, Saito S, Maruyama A, Yamaura T, Rokuhara A, Orii K, Ichijo T, Matsumoto A, Tanaka E, Kiyosawa K
    Tissue Antigens, 61(2), 159-165, 2003年WebofScience
  • Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; A marker distinct from viral DNA for monitoring lamivudine treatment.
    Rokuhara, A; Kimura, T; Matsumoto, A; Tanaka, E; Maki, N; Kiyosawa, K
    Hepatology, 38(4), 726A-727A, 2003年WebofScience
  • Analysis of the genotype-determining region of hepatitis A viral RNA in relation to disease severities
    Fujiwara, K; Yokosuka, O; Imazeki, F; Saisho, H; Saotome, N; Suzuki, K; Okita, K; Tanaka, E; Omata, M
    HEPATOLOGY RESEARCH, 25(2), 124-134, 2003年WebofScience
  • Riskfactors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
    Imamura, H; Matsuyama, Y; Tanaka, E; Ohkubo, T; Hasegawa, K; Miyagawa, S; Sugawara, Y; Minagawa, M; Takayama, T; Kawasaki, S; Makuuchi, M
    JOURNAL OF HEPATOLOGY, 38(2), 200-207, 2003年WebofScience
  • NASHと非A非B非C型肝炎ウイルス
    田中直樹,田中榮司,清澤研道
    肝・胆・膵, 44, 471-476, 2002年
  • HCV感染の診断と検査 HCVコア抗原定量とHCVセログループ その利用法
    田中榮司
    臨床医, 28, 47-49, 2002年
  • HCV関連マーカー測定法の進歩
    田中榮司
    臨床検査, 46, 243-250, 2002年
  • ウイルス性肝炎の現況 SENウイルスとその臨床的意義
    田中榮司
    医学のあゆみ, 200, 33-36, 2002年
  • 慢性肝炎診療マニュアルをめぐって 肝炎ウイルスの血液感染/母子感染/その他
    田中榮司
    綜合臨床, 51, 1929-1934, 2002年
  • 2度の帝王切開を契機に増悪したと考えられる巨大肝血管腫によるKasabach-Merritt症候群の1例
    六波羅明紀,吉澤 要,山浦高裕,丸山敦史,折井幸司,一條哲也,田中榮司,角谷眞澄,清澤研道
    肝臓, 43, 185-191, 2002年
  • Clinical significance of TT virus infection in maintenance hemodialysis patients of an endemic area for hepatitis C infection
    Gad A, Tanaka E, Orii K, Rokuhara A, Nooman Z, El-Hamid Serwah A,El-Sherif A, El-Essawy M, Yoshizawa K, Kiyosawa K
    Hepatol Res, 22(1), 13-19, 2002年WebofScience
  • Epidemiology and clinical aspects on hepatitis C
    Higuchi M, Tanaka E, Kiyosawa K
    Jpn J Infect Dis, 55(3), 69-77, 2002年WebofScience
  • Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load
    Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Kiyosawa K, Maki N
    J Clin Microbiol, 40(2), 439-445, 2002年WebofScience
  • Characteristics of hepatocellular carcinoma in Japan
    Kiyosawa K, Tanaka E
    ONCOLOGY, 62, 5-7, 2002年WebofScience
  • SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C
    Umemura T, Alter HJ, Tanaka E, Orii K, Yeo AE, Shih JW, Matsumoto A, Yoshizawa K, Kiyosawa K
    Hepatology, 35(4), 953-959, 2002年WebofScience
  • Development of small hepatocellular carcinoma in a patient with chronic hepatitis C after 77 months of a sustained and complete response to interferon therapy
    Yamaura T, Matsumoto A, Rokuhara A, Ichijo T, Tanaka E, Hanazaki K, Kajikawa S, Kiyosawa K
    J Gastroenterol Hepatol, 17(11), 1229-1235, 2002年WebofScience
  • Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines
    Yoshizawa K, Cioca DP, Kawa S, Tanaka E, Kiyosawa K
    Cancer, 95(10), 2243-2251, 2002年WebofScience
  • The role of SEN virus infection in various liver diseases from different geographical regions.
    Umemura, T; Tanaka, E; Lee, WM; Ostapowicz, G; Heringlake, S; Manns, MP; Tasopoulos, NC; Hatzakis, A; Brown, KE; Young, NS; Wang, R; Yeo, A; Shih, J; Orii, K; Kiyosawa, K; Alter, HJ
    Hepatology, 36(4), 646A-646A, 2002年WebofScience
  • Soluble asialoglycoprotein receptors reflect the apoptosis of hepatocytes
    Kakegawa, T; Ise, H; Sugihara, N; Nikaido, T; Negishi, N; Akaike, T; Tanaka, E
    CELL TRANSPLANTATION, 11(5), 407-415, 2002年WebofScience
  • Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect
    Gad, A; Tanaka, E; Orii, K; Rokuhara, A; Nooman, Z; Serwah, AH; Shoair, M; Yoshizawa, K; Kiyosawa, K
    JOURNAL OF GASTROENTEROLOGY, 36(11), 753-758, 2001年WebofScience
  • Association between SEN virus infection and hepatitis C in Japan
    Umemura, T; Alter, HJ; Tanaka, E; Yeo, AET; Shih, JWK; Orii, K; Matsumoto, A; Yoshizawa, K; Kiyosawa, K
    JOURNAL OF INFECTIOUS DISEASES, 184(10), 1246-1251, 2001年WebofScience
  • SEN virus infection in high- and non-endemic areas for hepatitis C in Japan.
    Umemura, T; Alter, HJ; Tanaka, E; Yeo, AE; Shih, JW; Orii, K; Matsumoto, A; Yoshizawa, K; Kiyosawa, K
    Hepatology, 34(4), 487A-487A, 2001年WebofScience
  • 8-year birth cohort study of the seroepidemiology of Helicobacter pylori infection and hepatitis A virus in rural Japan
    Malaty, HM; Tanaka, E; Kumagai, T; Ota, H; Akamatsu, T; Kiyosawa, K; Graham, DY
    Gut, 49, A32-A32, 2001年WebofScience
  • Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan
    Orito, E; Ichida, T; Sakugawa, H; Sata, M; Horiike, N; Hino, K; Okita, K; Okanoue, T; Iino, S; Tanaka, E; Suzuki, K; Watanabe, H; Hige, S; Mizokami, M
    Hepatology, 34(3), 590-594, 2001年WebofScience
  • Development of a sensitive enzyme-immunoassay for hepatitis B virus core-related antigens.
    Kimura, T; Rokuhara, A; Sakamoto, Y; Yagi, S; Tanaka, E; Kiyosawa, K; Maki, N
    CLINICAL CHEMISTRY, 47(6), A94-A94, 2001年WebofScience
  • A birth cohort study of the seroepidemiologic association of Helicobacter pylori infection and Hepatitis A virus in rural Japan
    Malaty, HM; Tanaka, E; Kumagai, T; Ota, H; Akamatsu, ET; Kiyosawa, K; Graham, DY; Katsuyama, T
    GASTROENTEROLOGY, 120(5), A128-A128, 2001年WebofScience
  • Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene
    Hosaka, S; Kawa, S; Aoki, Y; Tanaka, E; Yoshizawa, K; Karasawa, Y; Hosaka, N
    FOOD AND CHEMICAL TOXICOLOGY, 39(6), 557-561, 2001年WebofScience
  • Strategy for lamivudine-resistant YMDD mutant-associated chronic hepatitis B
    Kiyosawa, K; Tanaka, E
    JOURNAL OF GASTROENTEROLOGY, 36(2), 139-141, 2001年WebofScience
  • Seroepidemiological study of hepatitis E virus infection in Japan using a newly developed antibody assay
    Tanaka E 他10名
    J Gastroenterol, 36(5), 317-321, 2001年WebofScience電子ジャーナル
  • Natural history of acute hepatitis C
    Tanaka E 他1
    J Gastroenterol Hepatol, 15 (suppl), E97-E104, 2000年WebofScience
  • Clinical significance of TT virus infection in patients with chronic liver disease and volunteer blood donors in Egypt
    Amal G, Tanaka E 他6名
    J Med Virol, 60(2), 177-181, 2000年WebofScience
  • Persistent infection mechanism of GB virus C/hepatitis G virus differs from that of hepatitis C virus
    Orii K, Tanaka E 他5名
    INTERVIROLOGY, 43(3), 139-145, 2000年WebofScience
  • Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA
    Tanaka E 他6名
    Hepatology, 32(2), 388-393, 2000年WebofScience
  • Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon
    Nishizawa, Y; Tanaka, E; Orii, K; Rokuhara, A; Ichijo, T; Yoshizawa, K; Kiyosawa, K
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 15(11), 1292-1297, 2000年WebofScience
  • The prevalence of SEN virus infection in Japanese patients with viral hepatitis and liver disease.
    Umemura, T; Yeo, AE; Shih, Y; Matsumoto, A; Orii, K; Tanaka, E; Kiyosawa, K; Primi, D
    Hepatology, 32(4), 381A-381A, 2000年WebofScience
  • De novo infection of hepatitis B virus in patients with orthotopic liver transplantation analysis by determining the complete sequence of the genome.
    Rokuhara, A; Tanaka, E; Yagi, S; Mizokami, M; Hashikura, Y; Kawasaki, S; Kiyosawa, K
    Hepatology, 32(4), 597A-597A, 2000年WebofScience
  • De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: Analysis by determining complete sequence of the genome
    Rokuhara, A; Tanaka, E; Yagi, S; Mizokami, M; Hashikura, Y; Kawasaki, S; Kiyosawa, K
    JOURNAL OF MEDICAL VIROLOGY, 62(4), 471-478, 2000年WebofScience
  • The role of hepatitis C virus infection in glomerulopathy
    Muramatsu, T; Hora, K; Ako, S; Tachibana, N; Hora, K; Tanaka, E
    HEPATOLOGY RESEARCH, 18(3), 190-202, 2000年WebofScience
  • A new era of interferon treatment for chronic hepatitis C is coming
    Kiyosawa, K; Tanaka, E
    JOURNAL OF GASTROENTEROLOGY, 35(8), 652-654, 2000年WebofScience
  • T cell repertoire in the liver of patients with primary biliary cirrhosis
    Inada, H; Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Umemura, T; Tanaka, E; Kiyosawa, K
    HUMAN IMMUNOLOGY, 61(7), 675-683, 2000年WebofScience
  • Risk factors contributing to early and late phases of intrahepatic recurrence of hepatocellular carcinoma (HCC) after hepatectomy.
    Imamura, H; Tanaka, E; Matsuyama, Y; Miyagawa, SI; Kawasaki, S; Kubota, K; Takayama, T; Makuuchi, M
    GASTROENTEROLOGY, 118(4), A916-A916, 2000年WebofScience
  • Analysis of T cell repertoire in the liver of patients with chronic hepatitis C
    Umemura, T; Yoshizawa, K; Ota, M; Katsuyama, Y; Inada, H; Tanaka, E; Kiyosawa,K
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 121(1), 120-126, 2000年WebofScience
  • Evidence from a nine-year birth cohort study in Japan of transmission pathways of Helicobacter pylori infection
    Malaty, HM; Kumagai, T; Tanaka, E; Ota, H; Kiyosawa, K; Graham, DY; Katsuyama, T
    JOURNAL OF CLINICAL MICROBIOLOGY, 38(5), 1971-1973, 2000年WebofScience
  • Relationship between histological prognosis of chronic hepatitis C and amount of hepatitis C virus core protein in serum
    Iijima, A; Tanaka, E; Kobayashi,M; Yagi, S; Mizokami, M; Kiyosawa, K
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 15(3), 311-319, 2000年WebofScience
  • Does GBV-C/HGV replicate in the liver?
    Tanaka, E
    JOURNAL OF GASTROENTEROLOGY, 34(6), 721-723, 1999年WebofScience
  • Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro
    Rumin, S; Berthillon, P; Tanaka, E; Kiyosawa, K; Trabaud, MA; Bizollon, T; Gouillat, C; Gripon, P; Guguen-Guillouzo, C; Inchauspe, G; Trepo, C
    JOURNAL OF GENERAL VIROLOGY, 80, 3007-3018, 1999年WebofScience
  • T cell repertoire in the liver ofpatients with autoimmune hepatitis
    Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Inada, H; Umemura, T; Tanaka, E; Kiyosawa, K
    HUMAN IMMUNOLOGY, 60(9), 806-815, 1999年WebofScience
  • GB virus C/hepatitis G virus
    Kiyosawa, K; Tanaka, E
    INTERVIROLOGY, 42(2-3), 185-195, 1999年WebofScience
  • Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination
    Vidalin, O; Tanaka, E; Spengler, U; Trepo, C; Inchauspe, G
    DNA AND CELL BIOLOGY, 18(8), 611-621, 1999年WebofScience
  • Transfusion-associated TT virus infection and its relationship to liver disease
    Matsumoto, A; Yeo, AET; Shih, JWK; Tanaka, E; Kiyosawa, K; Alter, HJ
    Hepatology, 30(1), 283-288, 1999年WebofScience
  • Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen
    Aoyagi, K; Ohue, C; Iida, K; Kimura, T; Tanaka, E; Kiyosawa, K; Yagi, S
    JOURNAL OF CLINICAL MICROBIOLOGY, 37(6), 1802-1808, 1999年WebofScience
  • Prevalence and disease association of TT virus infection in Japanese patients with viral hepatitis
    Orii, K; Tanaka, E; Umemura, T; Rokuhara, A; Iijima, A; Yoshizawa, K; Imai, H; Kiyosawa, K
    HEPATOLOGY RESEARCH, 14(2), 161-170, 1999年WebofScience
  • Transmission of and liver injury by TT virus in patients on maintenance hemodialysis
    Oguchi, T; Tanaka, E; Orii, K; Kobayashi, M; Hora, K; Kiyosawa, K
    JOURNAL OF GASTROENTEROLOGY, 34(2), 234-240, 1999年WebofScience
  • TT virus infection in an area of high-endemicity for hepatitisC
    Umemura, T; Tanaka, E; Ota, M; Orii, K; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K
    HEPATOLOGY RESEARCH, 13(3), 212-220, 1999年WebofScience電子ジャーナル
  • Detection of GB virus-C hepatitis G virus genome in peripheral blood mononuclear cells and liver tissue
    Kobayashi, M; Tanaka, E; Nakayama, J; Furuwatari, C; Katsuyama, T; Kawasaki, S; Kiyosawa, K
    JOURNAL OFMEDICAL VIROLOGY, 57(2), 114-121, 1999年WebofScience電子ジャーナル
  • Past and present hepatitis G virus infections in areas where hepatitis C is highly endemic and those where it is not endemic
    Tanaka E 他8名
    J Clin Microbiol, 36(1), 110-114, 1998年WebofScience電子ジャーナル
  • Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: Report of a case
    Kita, Y; Lake, JR; Ferrell, LD; Mori, M; Roberts, JP; Kakizoe, S; Kiyosawa, K; Tanaka, E; Shiga, J; Takikawa, H; Inoue, Y; Ohtake, T; Ohtomo, K; Yotsuyanagi, H; Oka, T; Harihara, Y; Takayama, T; Kubota, K; Kawarasaki, H; Hashikura, Y; Kawasaki, S; Ascher, NL; Makuuchi, M
    TRANSPLANTATION PROCEEDINGS, 30(7), 3321-3323, 1998年WebofScience電子ジャーナル
  • T cell receptor usage of liver infiltrating T cells in patients with autoimmune hepatitis.
    Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Inada, H; Imai, H; Tanaka, E; Kiyosawa, K
    Hepatology, 28(4), 191A-191A, 1998年WebofScience
  • Clinical performance of quantitative and highly sensitive HCV core antigen assay system.
    Tanaka, E; Aoyagi, K; Nishizawa, Y; Umemura, T; Orii, K; Rokuhara, A; Iijima, A; Imai, H; Yoshizawa, K; Yagi, S; Hasegawa, A; Kiyosawa, K
    Hepatology, 28(4), 279A-279A, 1998年WebofScience
  • Development of highly sensitive enzyme-immunoassay for hepatitis C virus core antigen.
    Aoyagi, K; Ohue, C; Iida, K; Kimura, T; Tanaka, E; Kiyosawa, K; Yagi, S
    Hepatology, 28(4), 568A-568A, 1998年WebofScience
  • Acquistion vs. loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study
    Kumagai, T; Malaty, HM; Ota, H; Tanaka, E; Akamatsu, T; Kiyosawa, K; Graham, DY; Katsuyama, T
    Gut, 43, A39-A39, 1998年WebofScience
  • An 8-year birth cohort study shows adult-to-child transmission of H-pylori infection
    Malaty, HM; Kumagai, T; Ota, H; Tanaka, E; Akamatsu, T; Kiyosawa, K; Graham, DY; Katsuyama, T
    Gut, 43, A40-A40, 1998年WebofScience
  • Acquisition versus loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study
    Kumagai, T; Malaty, HM; Graham, DY; Hosogaya, S; Misawa, K; Furihata, K; Ota, H; Sei, C; Tanaka, E; Akamatsu, T; Shimizu, T; Kiyosawa, K; Katsuyama, T
    JOURNAL OF INFECTIOUS DISEASES, 178(3), 717-721, 1998年WebofScience電子ジャーナル
  • Prospective follow-up study of hepatitis C virus infection in patients undergoing maintenance haemodialysis: Comparison among haemodialysis units
    Kobayashi, M; Tanaka, E; Oguchi, H; Hora, K; Kiyosawa, K
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 13(6), 604-609, 1998年WebofScience電子ジャーナル
  • Clinical application of hepatitis C virus core protein in early diagnosis of acute hepatitis C
    Kobayashi, M; Tanaka, E; Matsumoto, A; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K
    JOURNAL OF GASTROENTEROLOGY, 33(4), 508-511, 1998年WebofScience電子ジャーナル
  • Two patients with acute hepatitis B with suspected sexual transmission of hepatitis G virus
    Tanaka, E; Nakatsuji, Y; Kobayashi, M; Orii, K; Kiyosawa, K
    JOURNAL OF GASTROENTEROLOGY, 33(3), 419-423, 1998年WebofScience電子ジャーナル
  • Acquisition and loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study.
    Kumagai, T; Hosogaya, S; Misawa, K; Furihata, K; Ota, H; Sei, C; Tanaka, E; Akamatsu, T; Shimizu, T; Kiyosawa, K; Katsuyama, T
    GASTROENTEROLOGY, 114(4), A190-A190, 1998年WebofScience電子ジャーナル
  • Adult-to-child transmission of Helicobacter pylori infection: Results from an 8-year birth cohort study.
    Malaty, HM; Graham, DY; Kumagai, T; Hosogaya, S; Misawa, K; Furihata, K; Ota, H; Sei, C; Tanaka, E; Akamatsu, T; Shimizu, T; Kiyosawa, K; Katsuyama, T
    GASTROENTEROLOGY, 114(4), A211-A211, 1998年WebofScience
  • Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis
    TANAKA Eiji 他7名
    J Viral Hepatitis, 5(3), 153-159, 1998年WebofScience電子ジャーナル
  • Clinical significance of hepatitis G virus infection in patients on long-term haemodialysis
    Ideura, T; Tanaka, E; Nakatsuji, Y; Kobayashi, M; Kanno, Y; Oguchi, H; Hora, K
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 12(11), 762-765, 1997年WebofScience
  • Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery frominfection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors
    Tacke, M; Schmolke, S; Schlueter, V; Sauleda, S; Esteban, JI; Tanaka, E; Kiyosawa, K; Alter, HJ; Schmitt, U; Hess, G; OfenlochHaehnle, B; Engel, AM
    Hepatology, 26(6), 1626-1633, 1997年WebofScience
  • Past and present infections ofhepatitis G virus in high-endemic area for hepatitis C; Comparison with nonendemic area.
    Tanaka, E; Tacke, M; Kobayashi, M; Nakatsuji, Y; Kiyosawa, K; Schmolke, S; Engel, AM; Hess, G; Alter, HJ
    Hepatology, 26(4), 797-797, 1997年WebofScience
  • Long-term prognosis of type C chronic hepatitis patients treated with interferon; Development of hepatocellular carcinoma.
    Iijima, A; Sodeyama, T; Inada, H; Ichijo, T; Kobayashi, M; Yamada, S; Imai, H; Yoshizawa, K; Tanaka, E; Kiyosawa, K
    Hepatology, 26(4), 1599-1599, 1997年WebofScience
  • Hepatitis G virus GB virus C infection in an area of high endemic hepatitis C virus infection
    Tanaka, E; Nakatsuji, Y; Kobayashi, M; Iijima, A; Ichijo, T; Imai, H; Yoshizawa, K; Sodeyama, T; Kiyosawa, K
    HEPATOLOGY RESEARCH, 7(2), 130-135, 1997年WebofScience
  • Quantitative measurement of HCV RNA in the serum: A comparison of three assays based on different principles
    Ichijo, T; Matsumoto, A; Kobayashi, M; Furihata, K; Tanaka, E
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 12(7), 500-506, 1997年WebofScience
  • A prospective trial to change the administration dose of interferon according to a decrease in serum HCV-RNA in chronic hepatitis C.
    Sodeyama, T; Matsumoto, A; Tanaka, E; Iizima, A; Yoshizawa, K; Imai, H; Kiyosawa, K
    GASTROENTEROLOGY, 112(4), A1386-A1386, 1997年WebofScience
  • Autoimmune hepatitis type 1 without evidence of hepatitis G virus infection
    Ichijo, T; Nakatsuji, Y; Tanaka, E; Alter, HJ; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K
    INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 6(5), 219-224, 1997年WebofScience
  • Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C
    Kobayashi, M; Tanaka, E; Matsumoto, A; Ichijo, T; Kiyosawa, K
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 12(1), 73-76, 1997年WebofScience
  • Hepatitis G virus GB virus C infection in patients with chronic non-B, non-C hepatitis
    Tanaka, E; Yamaguchi, K; Uemura, K; Kobayashi, M; Iijima, A; Kiyosawa, K; Yagi, S; Hasegawa, A
    INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 6(3-4), 137-143, 1997年WebofScience
  • Effect of hepatitis G virus infection on chronic hepatitis C
    Tanaka E 他8名
    Ann Intern Med, 125(9), 740-743, 1996年WebofScience
  • Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa
    Tanaka E 他7名
    Hepatology, 23(6), 1330-1333, 1996年WebofScience
  • The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses
    Kobayashi M, Tanaka E 他4名
    Hepatology, 23(4), 695-699, 1996年WebofScience
  • Budd-Chiari syndrome caused by hepatic vein thrombosis in a patient with myeloproliferative disorder
    Usui, T; Kitano, K; Midorikawa, T; Yoshizawa, K; Kobayashi, H; Tanaka, E; Matsunami, H; Kawasaki, S; Kiyosawa, K
    INTERNAL MEDICINE, 35(11), 871-875, 1996年WebofScience
  • Prevalence and disease association of hepatitis G virus infection in Japan
    Nakatsuji, Y; Shih, JWK; Tanaka, E; Kiyosawa, K; Wages, J; Kim, JP; Alter, HJ
    JOURNAL OF VIRAL HEPATITIS, 3(6), 307-316, 1996年WebofScience
  • Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis
    Shimodaira, S; Ishida, F; Ichikawa, N; Tahara, T; Kato, T; Kodaira, H; Ito, T; Tanaka, E; Sodeyama, T; Kiyosawa, K; Kitano, K
    THROMBOSIS AND HAEMOSTASIS, 76(4), 545-548, 1996年WebofScience
  • Effect of hepatitis G virus co-infection on patients with chronic hepatitis C
    Tanaka, E; Alter, HJ; Nakatsuji, Y; Shih, JWK; Kim, JP; Matsumoto, A; Kobayashi, M; Kiyosawa, K
    Hepatology, 24(4), 400-400, 1996年WebofScience
  • Hepatitis G virus (HGV) infection in Japanese patients infected with hepatitis C virus (HCV).
    Nakatsuji, Y; Shih, JWK; Kobayashi, M; Tanaka, E; Kiyosawa, K; Kim, JP; Alter, HJ
    Hepatology, 24(4), 403-403, 1996年WebofScience
  • Lymphocyte proliferative responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C
    Mori, H; Yabu, K; Yoshizawa, K; Tanaka, E; Kiyosawa, K
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 11(8), 697-704, 1996年WebofScience
  • Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA)
    Kashiwakuma, T; Hasegawa, A; Kajita, T; Takata, A; Mori, H; Ohta, Y; Tanaka,E;Kiyosawa, K; Tanaka, T; Tanaka, S; Hattori, N; Kohara, M
    JOURNAL OF IMMUNOLOGICAL METHODS, 190(1), 79-89, 1996年WebofScience
  • Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia
    Tanaka, T; Lau, JYN; Mizokami, M; Orito, E; Tanaka, E; Kiyosawa, K; Yasui, K; Ohta, Y; Hasegawa, A; Tanaka, S; Kohara, M
    JOURNAL OF HEPATOLOGY, 23(6), 742-745, 1995年WebofScience
  • Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis
    Shimodaira, S; Ishida, F; Ichikawa, N; Tahara, T; Kato, T; Kodaira, H; Ito, T; Tanaka, E; Sodeyama, T; Kiyosawa, K; Kitano, K
    BLOOD, 86(10), 3621-3621, 1995年WebofScience
  • EPIDEMIOLOGY OF GENOTYPES OF HEPATITIS-C VIRUS IN JAPANESE PATIENTS WITHTYPE-C CHRONIC LIVER-DISEASES - A MULTI-INSTITUTION ANALYSIS
    TANAKA, E; KIYOSAWA, K; MATSUSHIMA, T; ISHIKAWA, K; HINO, K; TANAKA, S; NOSE, H; KUMADA, H; IINO, S; KAMIMURA, T; UNOURA, M; MIZOKAMI, M; OKANOUE, T; KUROKI, T; YAMADA, G; MIURA, T; YANO, M; TSUBOUCHI, H; KOHARA, M; SATO, S; HATTORI, N; FURUTA, S; KARINO, Y; SAINOKAMI, S; TANAKA, T; OKADA, S; CHAYAMA, K; YASUDA, K; KUWANA, K; KANEKO, S; MIZOGUCHI, N; YASUI, K; TAKEDA, T; KISHI, F; YATSUHASHI, H; MARUYAMA, T; TSUKIYAMAKOHARA, K
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 10(5), 538-545, 1995年WebofScience
  • ACUTE HEPATITIS-C TRANSMITTED BY NEEDLESTICK ACCIDENT DESPITE SHORT-DURATION INTERFERON TREATMENT
    NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; MATSUMOTO, A; ICHIJO, T; MIZOKAMI, M; FURUTA, S
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 10(5), 609-611, 1995年WebofScience
  • PREVALENCE OF HEPATITIS-G VIRUS (HGV) IN JAPAN
    NAKATSUJI, Y; SHIH, JWK; TANAKA, E; WAGES, J; KIYOSAWA, K; KIM, JP; ALTER, HJ
    Hepatology, 22(4), 303-303, 1995年WebofScience
  • CLINICAL-APPLICATION OF A FLUORESCENCE ENZYME-IMMUNOASSAY FOR HCV CORE PROTEIN
    TANAKA, E; MATSUMOTO, A; KOBAYASHI, M; ICHIJO, T; IMAI, H; SODEYAMA, T; KIYOSAWA, K; OHTA, Y; HASEGAWA, A; KOHARA, M
    Hepatology, 22(4), 995-995, 1995年WebofScience
  • SIMPLE FLUORESCENT EIA FOR DETECTION AND QUANTIFICATION OF HEPATITIS-C VIREMIA
    Tanaka, T; Lau, JYN; Mizokami, M; Orito, E; Tanaka, E; Kiyosawa, K; Yasui, K; Ohta, Y; Hasegawa, A; Tanaka, S; Kohara, M
    Hepatology, 22(4), 996-996, 1995年WebofScience
  • USEFULNESS OF SIMPLE ASSAYS FOR SERUM CONCENTRATION OF HEPATITIS-C VIRUS-RNA AND HCV GENOTYPE IN PREDICTING THE RESPONSE OF PATIENTS WITH CHRONIC HEPATITIS-C TO INTERFERON ALPHA-2A THERAPY
    SUZUKI, T; TANAKA, E; MATSUMOTO, A; URUSHIHARA, A; SODEYAMA, T
    JOURNAL OF MEDICAL VIROLOGY, 46(2), 162-168, 1995年WebofScience
  • NATURAL-HISTORY OF HEPATITIS-C
    KIYOSAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, S
    INTERVIROLOGY, 37(2), 101-107, 1994年WebofScience
  • IMMUNOPEROXIDASE STAINING OF HEPATITIS-C VIRUS IN FORMALIN-FIXED, PARAFFIN-EMBEDDED NEEDLE LIVER BIOPSIES
    UCHIDA, T; SHIKATA, T; TANAKA, E; KIYOSAWA, K
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 424(5), 465-469, 1994年WebofScience
  • PREVALENCE OF HEPATITIS-C VIRUS WITH DIFFERENT GENOTYPES DETERMINED BY A GROUP-SPECIFIC ANTIBODY-ASSAY IN JAPANESE PATIENTS WITH CHRONIC LIVER-DISEASES DUE TO HEPATITIS-C VIRUS-INFECTION
    TANAKA, E; KIYOSAWA, K; MATSUMOTO, A; SODEYAMA, T; URUSHIHARA, A; SUZUKI, T; KOBAYASHI, M; FURUTA, S
    JAPANESE JOURNAL OF MEDICAL SCIENCE&BIOLOGY, 47(1), 47-57, 1994年WebofScience
  • VIRAL AND HOST FACTORS THAT CONTRIBUTE TO EFFICACY OF INTERFERON-ALPHA(2A) THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C
    MATSUMOTO, A; TANAKA, E; SUZUKI, T; OGATA, H; KIYOSAWA, K
    DIGESTIVE DISEASES AND SCIENCES, 39(6), 1273-1280, 1994年WebofScience
  • TRANSMISSION OF HEPATITIS-C IN AN ISOLATED AREA IN JAPAN - COMMUNITY-ACQUIRED INFECTION
    KIYOSAWA, K; TANAKA, E; SODEYAMA, T; YOSHIZAWA, K; YABU, K; FURUTA, K; IMAI, H; NAKANO, Y; USUDA, S;UEMURA, K; FURUTA, S; WATANABE, Y; WATANABE, J; FUKUDA, Y; TAKAYAMA, T; URUSHIBARA, A; MATSUMOTO, A; MORI, H; KOBAYASHI, M; SUZUKI, T; YAMADA, S; SEKI, T; SHIMIZU, S; NAKAMURA, M; SONE, H; HARA, K; ICHIJO, T; OHIKE, Y; GIBO, Y; NAKATSUJI, Y; YODA, H; TSUCHIYA, K; HAYATA, T; IMAI, Y; KOBAYASHI, M; HARA, N
    GASTROENTEROLOGY, 106(6), 1596-1602, 1994年WebofScience
  • SERUM COLLAGEN TYPE-IVFOR THE ASSESSMENT OF FIBROSIS AND RESISTANCE TO INTERFERON THERAPY IN CHRONIC HEPATITIS-C
    YABU, K; KIYOSAWA, K; MORI, H; MATSUMOTO, A; YOSHIZAWA, K; TANAKA, E; FURUTA, S
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 29(5), 474-479, 1994年WebofScience
  • ADAPTATION OF HEPATITIS-C VIRUS FOR PERSISTENT INFECTION IN PATIENTS WITH ACUTE HEPATITIS
    YAMAGUCHI, K; TANAKA, E; HIGASHI, K; KIYOSAWA, K; MATSUMOTO, A; FURUTA, S; HASEGAWA, A; TANAKA, S; KOHARA, M
    GASTROENTEROLOGY, 106(5), 1344-1348, 1994年WebofScience
  • SILENT HEPATITIS-B VIRUS MUTANTS ARE RESPONSIBLE FOR NON-A, NON-B, NON-C, NON-D, NON-E HEPATITIS
    UCHIDA, T; SHIMOJIMA, M; GOTOH, K; SHIKATA, T; TANAKA, E; KIYOSAWA, K
    MICROBIOLOGY AND IMMUNOLOGY, 38(4), 281-285, 1994年WebofScience
  • CHANGES IN ANTIBODY-TITERS TO HEPATITIS-C VIRUS FOLLOWING INTERFERON THERAPY FOR CHRONIC INFECTION
    URUSHIHARA, A; SODEYAMA, T; MATSUMOTO, A; TANAKA, E
    JOURNAL OF MEDICAL VIROLOGY, 42(4), 348-356, 1994年WebofScience
  • TYPE C CHRONIC HEPATITIS ASSOCIATED WITH THROMBOCYTOPENIA IN 2 PATIENTS
    YABU, K; KIYOSAWA, K; AKO, S; USUDA, S; YOSHIZAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, S
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 9(1), 99-104, 1994年WebofScience
  • QUANTITATIVE ASSAY FOR ANTI-HCV-CORE ANTIBODY IN HEALTHY-INDIVIDUALS FOUND ANTI-HCV POSITIVE DURING A MASS-SCREENING
    URUSHIHARA, A; SUZUKI, T; MATSUMOTO, A; TANAKA, E; SODEYAMA, T; KIYOSAWA, K; FURUTA, S
    INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 2(1), 47-51, 1994年WebofScience
  • HUMAN-LEUKOCYTE ANTIGEN CLASS-II MOLECULES AND PRIMARY BILIARY-CIRRHOSIS SUSCEPTIBILITY IN JAPANESE PATIENTS
    SEKI, T; KIYOSAWA, K; OTA, M; FURUTA, S; FUKUSHIMA, H; TANAKA, E; YOSHIZAWA, K; MIZUKI, N; ANDO, A; INOKO, H
    Hepatology, 18(4), A218-A218, 1993年WebofScience
  • IMMUNE-RESPONSES TO HCV ANTIGENS OF THE PATIENTS WITH DIFFERENT HISTOLOGICAL STAGES IN CHRONIC HEPATITIS-C
    MORI, H; YABU, K; YOSHIZAWA, K; USUDA, S; TANAKA, E; KIYOSAWA, K; HASEGAWA, A; KOHARA, M; FURUTA, S
    Hepatology, 18(4), A245-A245, 1993年WebofScience
  • FACTORS THAT CONTRIBUTE TO THE EFFICACY OF IFN THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C
    TANAKA, E; MATSUMOTO, A; SUZUKI, T; URUSHIHARA, A; YOSHIZAWA, K; SODEYAMA, T; KIYOSAWA, K; FURUTA, S
    Hepatology, 18(4), A258-A258, 1993年WebofScience
  • LOW-PREVALENCE OF HEPATITIS-C VIRUS-INFECTION IN PATIENTS WITH AUTOIMMUNE HEPATITIS TYPE-1
    TANAKA, E; KIYOSAWA, K; SEKI, T; MATSUMOTO, A; SODEYAMA, T; FURUTA, S; KUMAGAI, T; KOHARA, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 8(5), 442-447, 1993年WebofScience
  • PROGNOSIS OF ASYMPTOMATIC HEPATITIS-B SURFACE-ANTIGEN CARRIERS
    KIYOSAWA, K; SODEYAMA, T; TANAKA, E
    ANNALS OF INTERNAL MEDICINE, 119(6), 535-535, 1993年WebofScience
  • DETECTION OF HEPATITIS-C VIRUS MARKERS AND HEPATITIS-C VIRUS GENOMIC RNA AFTER NEEDLESTICK ACCIDENTS
    SODEYAMA, T; KIYOSAWA, K; URUSHIHARA, A; MATSUMOTO, A; TANAKA, E; FURUTA, S; AKAHANE, Y
    ARCHIVES OF INTERNAL MEDICINE, 153(13), 1565-1572, 1993年WebofScience
  • ASSOCIATION OF PRIMARY BILIARY-CIRRHOSIS WITH HUMAN-LEUKOCYTE ANTIGEN-DPB1-ASTERISK-0501 IN JAPANESE PATIENTS
    SEKI, T; KIYOSAWA, K; OTA, M; FURUTA, S; FUKUSHIMA, H; TANAKA, E; YOSHIZAWA, K; KUMAGAI, T; MIZUKI, N; ANDO, A; INOKO, H
    Hepatology, 18(1), 73-78, 1993年WebofScience
  • PROLIFERATIVE ACTIVITY OF HEPATOCYTES IN CHRONIC VIRAL-HEPATITIS AS REVEALED BY IMMUNOHISTOCHEMISTRY FOR PROLIFERATING CELL NUCLEAR ANTIGEN
    NAKAMURA, T; HAYAMA, M; SAKAI, T; HOTCHI, M; TANAKA, E
    HUMAN PATHOLOGY, 24(7), 750-753, 1993年WebofScience
  • COMPARISON OF SEROEPIDEMIOLOGY OF HEPATITIS-C IN BLOOD-DONORS BETWEEN BANGLADESH AND JAPAN
    KHAN, M; HUSAIN, M; YANO, M; HASHIZUME, K; YOUSUF, M; TANAKA, E; MATSUMOTO, A; FURUTA, S; KIYOSAWA, K
    GASTROENTEROLOGIA JAPONICA, 28, 28-31, 1993年WebofScience
  • ANTI-C100 ANTIBODIES TO HEPATITIS-C VIRUS IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS-INFECTION TREATED WITH INTERFERON
    NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; YOSHIZAWA, K; FURUTA, K; NAKATSUJI, Y; URUSHIHARA, A; FURUTA, S
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 28(4), 335-342, 1993年WebofScience
  • COMPARISON OF THE CLINICAL AND IMMUNOGENETIC FEATURES BETWEEN PATIENTS WITH AUTOIMMUNE HEPATITIS AND PATIENTS WITH TYPE-C CHRONICACTIVE HEPATITIS
    KIYOSAWA, K; SEKI, T; TANAKA, E; SODEYAMA, T; FURUTA, K; FURUTA, S; HINO, K; OTA, M; INOKO, H
    GASTROENTEROLOGIA JAPONICA, 28, 63-68, 1993年WebofScience
  • CLINICAL-SIGNIFICANCE OF ANTIBODIES TO NONSTRUCTURAL AND CORE PROTEINS OF HEPATITIS-C VIRUS IN POSTTRANSFUSION HEPATITIS PATIENTS DURING LONG-TERM FOLLOW-UP
    TANAKA, E; KIYOSAWA, K; NAKATSUJI, Y; INOUE, Y; MIYAMURA, T; CHIBA, J; FURUTA, S
    JOURNAL OF MEDICAL VIROLOGY, 39(4), 318-324, 1993年WebofScience
  • CAROLIS-DISEASE IN 3 SIBLINGS
    YOSHIZAWA, K; KIYOSAWA, K; YABU, K; USUDA, S; SHIMIZU,S; FUJIMORI, Y; MUKAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, S
    GASTROENTEROLOGIA JAPONICA, 27(6), 780-784, 1992年WebofScience
  • PERFORMANCE OF AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY SYSTEM FOR ANTIBODIES TO HEPATITIS-C VIRUS WITH 2 NEW ANTIGENS (C11/C7)
    SAITO, M; HASEGAWA, A; KASHIWAKUMA, T; KOHARA, M; SUGI, M; MIKI, K; YAMAMOTO, T; MORI, H; OHTA, Y; TANAKA, E; KIYOSAWA, K; FURUTA, S; WAKASHIMA, M; TANAKA, S; HATTORI, N
    CLINICAL CHEMISTRY, 38(12), 2434-2439, 1992年WebofScience
  • IMMUNOSUPPRESSIVE THERAPY PROMOTES THE REPLICATION OF HEPATITIS-C VIRUS, FOLLOWED BY EXACERBATION OF LIVER-DISEASE AFTER DOSAGE REDUCTION OR WITHDRAWAL
    NAKATSUJI, Y; KIYOSAWA, K; FURIHATA, K; TANAKA, E; MATSUMOTO, A; SODEYAMA, T; FURUTA, S; MAKUUCHI, M
    Hepatology, 16(4), A215-A215, 1992年WebofScience
  • PERSISTENCE OF VIREMIA IN PATIENTS WITH TYPE-C CHRONIC HEPATITIS DURING LONG-TERM FOLLOW-UP
    YOUSUF, M; NAKANO, Y; TANAKA, E; SODEYAMA, T; KIYOSAWA, K
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 27(9), 812-816, 1992年WebofScience
  • NEW HEPATOCELLULAR-CARCINOMA CELL-LINE SUHC-1 ESTABLISHED FROM A PATIENT WITH HEPATITIS-C VIRUS-RNA IN SERUM
    YOSHIZAWA, K; KIYOSAWA, K; USUDA, S; YABU, K; NAKATSUJI, Y; YAMADA, S; FURUTA, K; TANAKA, E; SODEYAMA, T; FURUTA, S; KANEKO, S; NAKANE, PK
    JAPANESE JOURNAL OF CANCER RESEARCH, 83(8), 871-877, 1992年WebofScience
  • DETECTION OF CHRONIC HEPATITIS-C VIRUS-INFECTION BY 4 DIAGNOSTIC SYSTEMS - 1ST-GENERATION AND 2ND-GENERATION ENZYME-LINKED-IMMUNOSORBENT-ASSAY, 2ND-GENERATION RECOMBINANT IMMUNOBLOT ASSAY AND NESTED POLYMERASE CHAIN-REACTION ANALYSIS
    NAKATSUJI, Y; MATSUMOTO, A; TANAKA, E; OGATA, H; KIYOSAWA, K
    Hepatology, 16(2), 300-305, 1992年WebofScience
  • HEPATITIS-VIRUS INFECTION (HBV AND HCV) IN 11 JAPANESE HEMODIALYSIS UNITS
    OGUCHI, H; MIYASAKA, M; TOKUNAGA, S;HORA, K; ICHIKAWA, S; OCHI, T; YAMADA, K; NAGASAWA, M; KANNO, Y; AIZAWA, T; WATANABE, H; YOSHIZAWA, S; SATO, K; TERASHIMA, M; YOSHIE, T; OGUCHI, S; TANAKA, E; KIYOSAWA, K; FURUTA, S
    CLINICAL NEPHROLOGY, 38(1), 36-43, 1992年WebofScience
  • PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN JAPANESE SCHOOLCHILDREN - COMPARISON WITH ADULT-BLOODDONORS
    TANAKA, E; KIYOSAWA, K; SODEYAMA, T; HAYATA, T; OHIKE, Y; NAKANO, Y; YOSHIZAWA, K; FURUTA, S; WATANABE, Y; WATANABE, I; NISHIOKA, K
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 46(4), 460-464, 1992年WebofScience
  • HIGH PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN HEAVY DRINKERS WITH CHRONIC LIVER-DISEASES IN JAPAN
    SHIMIZU, S; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; NAKANO, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 7(1), 30-35, 1992年WebofScience
  • HEPATITIS-C IN HOSPITAL EMPLOYEES WITH NEEDLESTICK INJURIES
    KIYOSAWA, K; SODEYAMA, T; TANAKA, E; NAKANO, Y; FURUTA, S; NISHIOKA, K; PURCELL, RH; ALTER, HJ
    ANNALS OF INTERNAL MEDICINE, 115(5), 367-369, 1991年WebofScience
  • EXPRESSION OF HEPATITIS-B SURFACE-ANTIGEN SUBTYPES IN LIVER OF PATIENTS WITH HEPATOCELLULAR-CARCINOMA - COMPARISON OF SUBTYPES IN SERUM AND LIVER
    NAKATSUJI, Y; KIYOSAWA, K; TANAKA, E; SODEYAMA, T; HORIGOME, N; KAJIKAWA,S; NAITO, S; AKAHANE, Y
    LIVER, 11(3), 176-184, 1991年WebofScience
  • INTRAFAMILIAL TRANSMISSION OF HEPATITIS-C VIRUS IN JAPAN
    KIYOSAWA, K; SODEYAMA, T; TANAKA, E; SHIMIZU, S; FURUTA, S; MIYAZAKI, Y; AKAHANE, Y; SUZUKI, H
    JOURNAL OF MEDICAL VIROLOGY, 33(2), 114-116, 1991年WebofScience
  • SIGNIFICANCE OF ANTIBODY TO HEPATITIS-C VIRUS IN JAPANESE PATIENTS WITH VIRAL-HEPATITIS - RELATIONSHIP BETWEEN ANTI-HCV ANTIBODY AND THE PROGNOSIS OF NON-A, NON-B POSTTRANSFUSION HEPATITIS
    TANAKA, E; KIYOSAWA, K; SODEYAMA, T; NAKANO, Y; YOSHIZAWA, K; HAYATA, T; SHIMIZU, S; NAKATSUJI, Y; KOIKE, Y; FURUTA, S
    JOURNAL OF MEDICAL VIROLOGY, 33(2), 117-122, 1991年WebofScience
  • A HIGH PREVALENCE OF ANTIBODY TO THE HEPATITIS-C VIRUS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA IN JAPAN
    NISHIOKA, K; WATANABE, J; FURUTA, S; TANAKA, E; IINO, S; SUZUKI, H; TSUJI, T; YANO, M; KUO, G; CHOO, QL; HOUGHTON, M; ODA, T
    Cancer, 67(2), 429-433, 1991年WebofScience
  • TRANSITION OF ANTIBODY TO HEPATITIS-C VIRUS FROM CHRONIC HEPATITIS TO HEPATOCELLULAR-CARCINOMA
    KIYOSAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, K; USUDA, S; YOUSUF, M; FURUTA, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 81(11), 1089-1091, 1990年WebofScience
  • INTERRELATIONSHIP OF BLOOD-TRANSFUSION, NON-A, NON-B HEPATITIS AND HEPATOCELLULAR-CARCINOMA - ANALYSIS BY DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS
    KIYOSAWA, K; SODEYAMA, T; TANAKA, E; GIBO, Y; YOSHIZAWA, K; NAKANO, Y; FURUTA, S; AKAHANE, Y; NISHIOKA, K; PURCELL, RH; ALTER, HJ
    Hepatology, 12(4), 671-675, 1990年WebofScience
  • PREVALENCE OF ANTI-HCV ANTIBODY IN BLOOD-DONORS IN THE TOKYO AREA
    WATANABE, J; MINEGISHI, K; MITSUMORI, T; ISHIFUJI, M; OGUCHI, T; UEDA, M; TOKUNAGA, E; TANAKA, E; KIYOSAWA, K; FURUTA, S; KATAYAMA, T; KUO, G; CHOO, QL; HOUGHTON, M; NISHIOKA, K
    VOX SANGUINIS, 59(2), 86-88, 1990年WebofScience
  • COMPARATIVE-STUDY OF CLINICAL, HISTOLOGICAL, AND IMMUNOLOGICAL RESPONSES TO INTERFERON THERAPY IN TYPE-NON-A, TYPE-NON-B, AND TYPE-B CHRONIC HEPATITIS
    NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 85(1), 24-29, 1990年WebofScience
  • Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection
    Joshita S, Sugiura A, Umemura T, Yamazaki T, Fujimori N, Matsumoto A, Usami Y, Tanaka E
    JGH Open

書籍等出版物

  • C型肝炎のおはなし
    田中榮司
    シスメックス株式会社, 1-14 2019年
  • B型肝炎のおはなし
    田中榮司
    シスメックス株式会社, 1-14 2019年
  • 日本肝臓学会(監修), 西口修平(監修), 上野義之, 日浅陽一, 榎本平之(編):肝硬変の成因別実態
    杉浦亜弓, 城下智, 髙橋芳之, 栗林直矢, 山崎智生, 藤森尚之, 梅村武司, 松本晶博, 田中榮司, 長野県における肝硬変の成因実態
    医学図書出版, 東京, 80-81 2019年
  • 金井正光編:臨床検査法提要第32版
    田中栄司, Ⅲ肝・胆道機能検査
    金原出版,東京, pp 1335-1387 2005年
  • 林紀夫編:ウィルス性肝炎 消化器3
    田中栄司, 急性肝炎の診断と治療(各論)(5)その他のウィルス性急性肝炎
    最新医学社,大阪, pp 106-114 2005年
  • 犬山シンポジウム記録刊行会編:ウイルス肝炎からの発癌とその予防
    清澤研道,松本晶博,田中榮司,犬山肝炎研究グループ, B型慢性肝炎に対するラミブジン治療調査報告
    アークメディア,東京, pp 159-165 2005年
  • 編:ウィルス性肝炎 消化器3
    松本晶博,田中榮司,清澤研道, B型慢性肝炎の予後(治療による発癌抑止)
    最新医学社,大阪, pp 171-176 2005年
  • 高久史麿,猿田亨男,北村惣一郎,福井次矢編:家庭医学大全科
    田中栄司, 肝臓の病気/肝炎 C型急性肝炎 C型慢性肝炎 B型漫性肝炎
    法研,東京, pp 2023-2029 2004年
  • 二ノ宮節夫,冨士川恭輔,越知隆弘,国分正一,岩谷力編:今日の整形外科治療指針第5版
    田中栄司, 術後肝障害の対策
    医学書院,東京, pp 32-32 2004年
  • 各務伸一編:コンセンサス2004肝疾患治療
    田中栄司, C型肝炎治療の総論
    アークメディア,東京, pp 77-83 2004年
  • 林 紀夫,岡上 武,熊田博光編:C型慢性肝炎治療の新たなストラテジー(インターフェロン治療の今後)
    田中栄司, C型慢性肝炎の治療とウイルスマーカー
    先端医学社,東京, pp 51-57 2004年
  • 清澤研道編:ナースのための肝炎看護ハンドブック C型肝炎対策を中心に
    田中栄司, C型肝炎の検査法
    医薬ジャーナル社,東京, pp 33-41 2004年
  • 清澤研道編:ナースのための肝炎看護ハンドブック C型肝炎対策を中心に
    田中栄司, C型肝炎の治療
    医薬ジャーナル社,東京, pp 42-53 2004年
  • 犬山シンポジウム記録刊行会編:B型・C型肝炎の病態と治療(第24回犬山シンポジウム)
    清澤研道,田中榮司,松本晶博,熊田博光,小俣正男, Lamivudine 治療はB型肝炎の自然経過を修飾するか
    アークメディア,東京, pp 3-9 2003年
  • 熊田博光編:医学のあゆみ
    田中榮司, ウイルス性肝炎の現況 SENウイルスとその臨床的意義
    医歯薬出版,東京, pp 31-34 2003年
  • 山口惠三,岩本愛吉編:日本臨床
    田中榮司, グローバル時代の感染症学 ウイルス感染症 ウイルス性肝炎 E型肝炎
    日本臨床社,東京, pp 249-253 2003年
  • 石橋大海編:今月の治療
    田中榮司, 慢性肝炎の治療と肝炎ウイルスマーカー
    総合医学社,東京, pp 1105-1108 2003年
  • Hepatitis C virus in the etiology of hepatocellular carcinoma. Tabor E: Virus and Liver Cancer
    Kiyosawa K, Tanaka E
    Elsevier, pp 31-42 2002年
  • Hepatocellular carcinoma and Hepatitis C. Sarin SK. Okuda K: Hepatitis B and C carrier to cancer
    Kiyosawa K, Tanaka E
    ELSEVIER INDIA, pp 315-329 2002年
  • C型肝炎,自然経過と予後.矢野右人,林紀夫,沖田極編:コンセンサス肝疾患2002診断・治療と病態
    田中榮司
    日本メディカルセンター, pp 114-123 2002年
  • C型肝硬変の生体肝移植.熊田博光編:C型慢性肝炎の治療最前線ー最近の知見と治療ー
    田中榮司
    メディカルレビュー社, pp 222-227 2002年
  • 新しいHBV定量系HBVコア関連抗原(HBcrAg)の臨床的応用性.犬山シンポジウム記録刊行会編:B型・C型肝炎治療の新たな展開
    六波羅明紀,田中榮司,松本晶博,木村達治,八木慎太郎,槇昇,清澤研道
    アークメディア, pp 15-19 2002年

所属学協会

  • 米国肝臓学会
  • 日本癌学会
  • 日本ウイルス学会
  • 日本消化器内視鏡学会

共同研究・競争的資金等の研究課題

  • 重症肝疾患の肝移植
  • B型肝炎の抗ウイルス療法
  • C型肝炎の抗ウイルス療法
  • 自己免疫性肝疾患の遺伝的背景
  • B型肝炎の再活性化
  • 脂肪性肝疾患の診断と治療

産業財産権

  • HBV-RNAを含むHBV粒子, 2003-83283, 特許権
  • B型肝炎ウイルスの薬物抵抗性を識別する方法, 2004-558464, 特許権
  • C型慢性肝炎の治療効果を事前に予測するためのキット, 8-167497, 特許権
  • 競合PCR法による核酸の簡易定量法, 6-71701, 特許権